Vitamin D axis in health and in renal disease.
\\n\\n
More than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\\n\\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\\n\\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\\n\\nAdditionally, each book published by IntechOpen contains original content and research findings.
\\n\\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\\n\\n\\n\\n
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'
Simba Information has released its Open Access Book Publishing 2020 - 2024 report and has again identified IntechOpen as the world’s largest Open Access book publisher by title count.
\n\nSimba Information is a leading provider for market intelligence and forecasts in the media and publishing industry. The report, published every year, provides an overview and financial outlook for the global professional e-book publishing market.
\n\nIntechOpen, De Gruyter, and Frontiers are the largest OA book publishers by title count, with IntechOpen coming in at first place with 5,101 OA books published, a good 1,782 titles ahead of the nearest competitor.
\n\nSince the first Open Access Book Publishing report published in 2016, IntechOpen has held the top stop each year.
\n\n\n\nMore than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\n\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\n\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\n\nAdditionally, each book published by IntechOpen contains original content and research findings.
\n\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\n\n\n\n
\n'}],latestNews:[{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"},{slug:"intechopen-s-chapter-awarded-the-guenther-von-pannewitz-preis-2020-20200715",title:"IntechOpen's Chapter Awarded the Günther-von-Pannewitz-Preis 2020"},{slug:"suf-and-intechopen-announce-collaboration-20200331",title:"SUF and IntechOpen Announce Collaboration"}]},book:{item:{type:"book",id:"10054",leadTitle:null,fullTitle:"Electrochemical Impedance Spectroscopy",title:"Electrochemical Impedance Spectroscopy",subtitle:null,reviewType:"peer-reviewed",abstract:"Electrochemical Impedance Spectroscopy is a compendium of contributions from experts in the field of electrochemical impedance spectroscopy (EIS). This compilation of investigations and reviews addresses the groundbreaking applications of EIS in different fields. An array of exploitations are revealed throughout this book such as the use of EIS in monitoring and controlling of corrosion, in medicine where accurate information on fluid distribution is needed as well as environmental applications in food, water, and drug analyses. Competency of EIS as an approach compared to the traditional electrochemical techniques is assessed in almost every application. This book, therefore, is a valuable reference for students, researchers, and anyone interested in electrochemical impedance spectroscopy.",isbn:"978-1-78985-216-5",printIsbn:"978-1-78985-215-8",pdfIsbn:"978-1-78985-677-4",doi:"10.5772/intechopen.87884",price:119,priceEur:129,priceUsd:155,slug:"electrochemical-impedance-spectroscopy",numberOfPages:168,isOpenForSubmission:!1,isInWos:null,hash:"853598dac262500c29850c27c5be6092",bookSignature:"Marwa El-Azazy, Mart Min and Paul Annus",publishedDate:"December 16th 2020",coverURL:"https://cdn.intechopen.com/books/images_new/10054.jpg",numberOfDownloads:1236,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:2,hasAltmetrics:0,numberOfTotalCitations:2,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 11th 2019",dateEndSecondStepPublish:"March 27th 2020",dateEndThirdStepPublish:"May 26th 2020",dateEndFourthStepPublish:"August 14th 2020",dateEndFifthStepPublish:"October 13th 2020",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6,7",editedByType:"Edited by",kuFlag:!1,editors:[{id:"198210",title:"Dr.",name:"Marwa",middleName:"S.",surname:"El-Azazy",slug:"marwa-el-azazy",fullName:"Marwa El-Azazy",profilePictureURL:"https://mts.intechopen.com/storage/users/198210/images/system/198210.png",biography:"Dr. Marwa El-Azazy is an analytical chemist and experienced educator and researcher with more than 15 years of teaching experience at several institutions. Her main research interest is construction of sensors (using microfluidic platforms for point-of-care-testing of drugs and bio-analytes and ion-selective electrodes), chemometrics and analytical method development, spectroscopic analyses of drugs and pharmaceuticals, synthesis and characterization of nanomaterials, and development of green chemistry approaches for wastewater treatment. Dr. Marwa has a track record of research inputs including more than thirty refereed papers in prestigious international journals, several conference presentations, and two book chapters, in addition to several research grants. She serves as a reviewer for a variety of international journals.",institutionString:"College of Arts and Sciences, Qatar University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"Qatar University",institutionURL:null,country:{name:"Qatar"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"62780",title:"Prof.",name:"Mart",middleName:null,surname:"Min",slug:"mart-min",fullName:"Mart Min",profilePictureURL:"https://mts.intechopen.com/storage/users/62780/images/system/62780.jpg",biography:"Dr. Mart Min has been a professor and leading scientist at Thomas Johann Seebeck Department of Electronics, Tallinn University of Technology, Estonia, since 1992. He has been professor emeritus since 2017. He obtained a Ph.D. in Measurement Science from Kyiv Polytechnic, Ukraine, in 1984. From 1992 to 1993, he was with the Technical University of Munich and Bundeswehr University in Munich, Germany. During 2007–2010, Dr. Min joined the Institute of Bioprocessing and Analytical Measurement Technique, Germany. From 2019 to 2020 he was a part-time professor at Riga Technical University, Latvia. His interests include the methods for the measurement of electrical impedance and processing of bioelectrical signals. Dr. Min is a Senior Life Member of the IEEE Instrumentation and Measurement and Engineering in Medicine and Biology Societies. He is also a member of the International Committee for Promotion of Research in Bio-Impedance (ICPRBI).",institutionString:"Tallinn University of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"Tallinn University of Technology",institutionURL:null,country:{name:"Estonia"}}},coeditorTwo:{id:"299124",title:"Dr.",name:"Paul",middleName:null,surname:"Annus",slug:"paul-annus",fullName:"Paul Annus",profilePictureURL:"https://mts.intechopen.com/storage/users/299124/images/system/299124.jpeg",biography:"Paul Annus, PhD, has been a teacher and entrepreneur since graduating in 1987. He has spent the last two decades working in engineering and project management in the local technology development center and research in the Tallinn University of Technology, where he currently works as a senior researcher, lecturer, and supervisor in the Thomas Johann Seebeck Department of Electronics. He is a member of the Institute of Electrical and Electronics Engineers. He has received awards for scientific papers, reviewing those papers, project leadership, and course development. His research interests include data acquisition, system identification, and especially bioimpedance spectroscopy. His emphasis is on reliable, scalable, and optimally deployable solutions for health monitoring. He has published more than 100 publications and registered thirteen inventions.",institutionString:"Tallinn University of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Tallinn University of Technology",institutionURL:null,country:{name:"Estonia"}}},coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"505",title:"Electrochemistry",slug:"chemistry-physical-chemistry-electrochemistry"}],chapters:[{id:"74147",title:"Electrochemical Impedance Spectroscopy (EIS): A Review Study of Basic Aspects of the Corrosion Mechanism Applied to Steels",doi:"10.5772/intechopen.94470",slug:"electrochemical-impedance-spectroscopy-eis-a-review-study-of-basic-aspects-of-the-corrosion-mechanis",totalDownloads:162,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Héctor Herrera Hernández, Adriana M. Ruiz Reynoso, Juan C. Trinidad González, Carlos O. González Morán, José G. Miranda Hernández, Araceli Mandujano Ruiz, Jorge Morales Hernández and Ricardo Orozco Cruz",downloadPdfUrl:"/chapter/pdf-download/74147",previewPdfUrl:"/chapter/pdf-preview/74147",authors:[{id:"114381",title:"Dr.",name:"Jorge",surname:"Morales-Hernandez",slug:"jorge-morales-hernandez",fullName:"Jorge Morales-Hernandez"},{id:"215540",title:"Dr.",name:"Araceli",surname:"Mandujano Ruiz",slug:"araceli-mandujano-ruiz",fullName:"Araceli Mandujano Ruiz"},{id:"268773",title:"Dr.",name:"Hector",surname:"Herrera Hernandez",slug:"hector-herrera-hernandez",fullName:"Hector Herrera Hernandez"},{id:"268774",title:"Dr.",name:"Carlos O.",surname:"Gonzalez Moran",slug:"carlos-o.-gonzalez-moran",fullName:"Carlos O. Gonzalez Moran"},{id:"314695",title:"Dr.",name:"Adriana Mercedes",surname:"Ruiz Reynoso",slug:"adriana-mercedes-ruiz-reynoso",fullName:"Adriana Mercedes Ruiz Reynoso"}],corrections:null},{id:"70749",title:"Electrochemical Impedance Spectroscopy (EIS) Characterization of Kitchen Utensils Used as Materials for Local Cooking in Two Culinary Media",doi:"10.5772/intechopen.90877",slug:"electrochemical-impedance-spectroscopy-eis-characterization-of-kitchen-utensils-used-as-materials-fo",totalDownloads:160,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Jacques Sawadogo and Jean Boukari Legma",downloadPdfUrl:"/chapter/pdf-download/70749",previewPdfUrl:"/chapter/pdf-preview/70749",authors:[{id:"313312",title:"Dr.",name:"Jacques",surname:"Sawadogo",slug:"jacques-sawadogo",fullName:"Jacques Sawadogo"},{id:"313326",title:"Prof.",name:"Jean Boukari",surname:"Legma",slug:"jean-boukari-legma",fullName:"Jean Boukari Legma"}],corrections:null},{id:"72420",title:"Electrochemical, Thermodynamic, Surface, and Spectroscopic Study in Inhibition of Iron Corrosion with Turmeric Root Extract (TRE)",doi:"10.5772/intechopen.92648",slug:"electrochemical-thermodynamic-surface-and-spectroscopic-study-in-inhibition-of-iron-corrosion-with-t",totalDownloads:88,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Khuloud Almzarzie, Ayman Almassri, Ahmad Falah and Hassan Kellawi",downloadPdfUrl:"/chapter/pdf-download/72420",previewPdfUrl:"/chapter/pdf-preview/72420",authors:[{id:"315207",title:"Dr.",name:"Khuloud",surname:"Almzarzie",slug:"khuloud-almzarzie",fullName:"Khuloud Almzarzie"},{id:"321075",title:null,name:"Ahmad",surname:"Falah",slug:"ahmad-falah",fullName:"Ahmad Falah"},{id:"321076",title:null,name:"Ayman",surname:"Almassri",slug:"ayman-almassri",fullName:"Ayman Almassri"},{id:"321077",title:null,name:"Hassan",surname:"Kellawi",slug:"hassan-kellawi",fullName:"Hassan Kellawi"}],corrections:null},{id:"71909",title:"Designing and Synthesis of (Cd2+, Li+), Cr3+, Bi3+ Doped CePO4 Materials Optical, Electrochemical, Ionic Conductivity Analysis",doi:"10.5772/intechopen.91330",slug:"designing-and-synthesis-of-cd-sup-2-sup-li-sup-sup-cr-sup-3-sup-bi-sup-3-sup-doped-cepo-sub-4-sub-ma",totalDownloads:112,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Salah Kouass, Amor Fadhalaoui, Hassouna Dhaouadi and Fathi Touati",downloadPdfUrl:"/chapter/pdf-download/71909",previewPdfUrl:"/chapter/pdf-preview/71909",authors:[{id:"217347",title:"Dr.",name:"Salah",surname:"Kouass",slug:"salah-kouass",fullName:"Salah Kouass"}],corrections:null},{id:"70855",title:"Circuit Models of Bioelectric Impedance",doi:"10.5772/intechopen.91004",slug:"circuit-models-of-bioelectric-impedance",totalDownloads:187,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Alexandru Gabriel Gheorghe, Florin Constantinescu, Miruna Nițescu and Mihai Eugen Marin",downloadPdfUrl:"/chapter/pdf-download/70855",previewPdfUrl:"/chapter/pdf-preview/70855",authors:[{id:"134882",title:"Prof.",name:"Florin",surname:"Constantinescu",slug:"florin-constantinescu",fullName:"Florin Constantinescu"},{id:"134885",title:"Prof.",name:"Miruna",surname:"Nitescu",slug:"miruna-nitescu",fullName:"Miruna Nitescu"},{id:"315687",title:"Prof.",name:"Alexandru",surname:"Gheorghe",slug:"alexandru-gheorghe",fullName:"Alexandru Gheorghe"},{id:"316255",title:"Prof.",name:"Mihai Eugen",surname:"Marin",slug:"mihai-eugen-marin",fullName:"Mihai Eugen Marin"}],corrections:null},{id:"70053",title:"Electrodermal Activity: Simultaneous Recordings",doi:"10.5772/intechopen.89025",slug:"electrodermal-activity-simultaneous-recordings",totalDownloads:204,totalCrossrefCites:0,totalDimensionsCites:2,signatures:"Haval Y. Yacoob Aldosky and Dindar S. Bari",downloadPdfUrl:"/chapter/pdf-download/70053",previewPdfUrl:"/chapter/pdf-preview/70053",authors:[{id:"305324",title:"Associate Prof.",name:"Haval",surname:"Yacoob Aldosky",slug:"haval-yacoob-aldosky",fullName:"Haval Yacoob Aldosky"},{id:"309032",title:"Dr.",name:"Dindar S.",surname:"Bari",slug:"dindar-s.-bari",fullName:"Dindar S. Bari"}],corrections:null},{id:"71012",title:"Experimental and Theoretical Study of the Adsorption Behavior of Nitrate Ions by Layered Double Hydroxide Using Impedance Spectroscopy",doi:"10.5772/intechopen.90883",slug:"experimental-and-theoretical-study-of-the-adsorption-behavior-of-nitrate-ions-by-layered-double-hydr",totalDownloads:81,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Abderrahmane Elmelouky, Abdelhadi Mortadi, Elghaouti Chahid and Reddad Elmoznine",downloadPdfUrl:"/chapter/pdf-download/71012",previewPdfUrl:"/chapter/pdf-preview/71012",authors:[{id:"313846",title:"Ph.D.",name:"Elmelouky",surname:"Abderrahmane",slug:"elmelouky-abderrahmane",fullName:"Elmelouky Abderrahmane"}],corrections:null},{id:"72014",title:"Electrochemical Impedance Spectroscopy (EIS) in Food, Water, and Drug Analyses: Recent Advances and Applications",doi:"10.5772/intechopen.92333",slug:"electrochemical-impedance-spectroscopy-eis-in-food-water-and-drug-analyses-recent-advances-and-appli",totalDownloads:242,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Marwa El-Azazy",downloadPdfUrl:"/chapter/pdf-download/72014",previewPdfUrl:"/chapter/pdf-preview/72014",authors:[{id:"198210",title:"Dr.",name:"Marwa",surname:"El-Azazy",slug:"marwa-el-azazy",fullName:"Marwa El-Azazy"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"6800",title:"Infrared Spectroscopy",subtitle:"Principles, Advances, and Applications",isOpenForSubmission:!1,hash:"8048b049a107a522e5885468bde858b1",slug:"infrared-spectroscopy-principles-advances-and-applications",bookSignature:"Marwa El-Azazy",coverURL:"https://cdn.intechopen.com/books/images_new/6800.jpg",editedByType:"Edited by",editors:[{id:"198210",title:"Dr.",name:"Marwa",surname:"El-Azazy",slug:"marwa-el-azazy",fullName:"Marwa El-Azazy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"21",title:"Ferroelectrics",subtitle:null,isOpenForSubmission:!1,hash:null,slug:"ferroelectrics",bookSignature:"Indrani Coondoo",coverURL:"https://cdn.intechopen.com/books/images_new/21.jpg",editedByType:"Edited by",editors:[{id:"289832",title:"Dr.",name:"Indrani",surname:"Coondoo",slug:"indrani-coondoo",fullName:"Indrani Coondoo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2549",title:"Ion Exchange Technologies",subtitle:null,isOpenForSubmission:!1,hash:"d5d70a346ca433c501e5968f54286740",slug:"ion-exchange-technologies",bookSignature:"Ayben Kilislioğlu",coverURL:"https://cdn.intechopen.com/books/images_new/2549.jpg",editedByType:"Edited by",editors:[{id:"139903",title:"Prof.",name:"Ayben",surname:"Kilislioglu",slug:"ayben-kilislioglu",fullName:"Ayben Kilislioglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2282",title:"Atomic Force Microscopy",subtitle:"Imaging, Measuring and Manipulating Surfaces at the Atomic Scale",isOpenForSubmission:!1,hash:"17fb7c8076806f6aca457071b7e7ce10",slug:"atomic-force-microscopy-imaging-measuring-and-manipulating-surfaces-at-the-atomic-scale",bookSignature:"Victor Bellitto",coverURL:"https://cdn.intechopen.com/books/images_new/2282.jpg",editedByType:"Edited by",editors:[{id:"111789",title:"Dr.",name:"Victor",surname:"Bellitto",slug:"victor-bellitto",fullName:"Victor Bellitto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5381",title:"Ionic Liquids",subtitle:"Progress and Developments in",isOpenForSubmission:!1,hash:"e87c37c4d014c11121453605e6d0f37a",slug:"progress-and-developments-in-ionic-liquids",bookSignature:"Scott Handy",coverURL:"https://cdn.intechopen.com/books/images_new/5381.jpg",editedByType:"Edited by",editors:[{id:"42658",title:"Prof.",name:"Scott",surname:"Handy",slug:"scott-handy",fullName:"Scott Handy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"607",title:"Electropolymerization",subtitle:null,isOpenForSubmission:!1,hash:"0457c6cc64766bdd64f8195b8e22afb1",slug:"electropolymerization",bookSignature:"Ewa Schab-Balcerzak",coverURL:"https://cdn.intechopen.com/books/images_new/607.jpg",editedByType:"Edited by",editors:[{id:"73293",title:"Dr.",name:"Ewa",surname:"Schab-Balcerzak",slug:"ewa-schab-balcerzak",fullName:"Ewa Schab-Balcerzak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1431",title:"Recent Trend in Electrochemical Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"9ec6b0bf8c309891f70a9c181399984e",slug:"recent-trend-in-electrochemical-science-and-technology",bookSignature:"Ujjal Kumar Sur",coverURL:"https://cdn.intechopen.com/books/images_new/1431.jpg",editedByType:"Edited by",editors:[{id:"27764",title:"Dr.",name:"Ujjal Kumar",surname:"Sur",slug:"ujjal-kumar-sur",fullName:"Ujjal Kumar Sur"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"159",title:"Superconductivity",subtitle:"Theory and Applications",isOpenForSubmission:!1,hash:"bb0587d06c5516fc4e3c89818b9b17e6",slug:"superconductivity-theory-and-applications",bookSignature:"Adir Moyses Luiz",coverURL:"https://cdn.intechopen.com/books/images_new/159.jpg",editedByType:"Edited by",editors:[{id:"10012",title:"Dr.",name:"Adir",surname:"Luiz",slug:"adir-luiz",fullName:"Adir Luiz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1455",title:"Electroplating",subtitle:null,isOpenForSubmission:!1,hash:"18ec8cf0e50c5e8170a9d0b20af09b7f",slug:"electroplating",bookSignature:"Darwin Sebayang and Sulaiman Bin Haji Hasan",coverURL:"https://cdn.intechopen.com/books/images_new/1455.jpg",editedByType:"Edited by",editors:[{id:"92970",title:"Prof.",name:"Darwin",surname:"Sebayang",slug:"darwin-sebayang",fullName:"Darwin Sebayang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4599",title:"Ion Exchange",subtitle:"Studies and Applications",isOpenForSubmission:!1,hash:"2e45cfed818bc38f70a214561b0a1e21",slug:"ion-exchange-studies-and-applications",bookSignature:"Ayben Kilislioglu",coverURL:"https://cdn.intechopen.com/books/images_new/4599.jpg",editedByType:"Edited by",editors:[{id:"139903",title:"Prof.",name:"Ayben",surname:"Kilislioglu",slug:"ayben-kilislioglu",fullName:"Ayben Kilislioglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"66302",slug:"corrigendum-to-the-role-of-cytokines-in-orthodontic-tooth-movement",title:"Corrigendum to: The Role of Cytokines in Orthodontic Tooth Movement",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/66302.pdf",downloadPdfUrl:"/chapter/pdf-download/66302",previewPdfUrl:"/chapter/pdf-preview/66302",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/66302",risUrl:"/chapter/ris/66302",chapter:{id:"63306",slug:"the-role-of-cytokines-in-orthodontic-tooth-movement",signatures:"Amila Vujacic, Jasna Pavlovic and Aleksandra Konic-Ristic",dateSubmitted:"April 22nd 2018",dateReviewed:"July 9th 2018",datePrePublished:"November 9th 2018",datePublished:"April 10th 2019",book:{id:"7139",title:"Current Approaches in Orthodontics",subtitle:null,fullTitle:"Current Approaches in Orthodontics",slug:"current-approaches-in-orthodontics",publishedDate:"April 10th 2019",bookSignature:"Belma Işık Aslan and Fatma Deniz Uzuner",coverURL:"https://cdn.intechopen.com/books/images_new/7139.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"42847",title:"Dr.",name:"Belma",middleName:null,surname:"Işık Aslan",slug:"belma-isik-aslan",fullName:"Belma Işık Aslan"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"255738",title:"Associate Prof.",name:"Amila",middleName:null,surname:"Vujacic",fullName:"Amila Vujacic",slug:"amila-vujacic",email:"amilavujacic@gmail.com",position:null,institution:null},{id:"264430",title:"Prof.",name:"Jasna",middleName:null,surname:"Pavlovic",fullName:"Jasna Pavlovic",slug:"jasna-pavlovic",email:"drjasnapavlovic@gmail.com",position:null,institution:null},{id:"264432",title:"Dr.",name:"Aleksandra",middleName:null,surname:"Konic",fullName:"Aleksandra Konic",slug:"aleksandra-konic",email:"sandrakonic@gmail.com",position:null,institution:null}]}},chapter:{id:"63306",slug:"the-role-of-cytokines-in-orthodontic-tooth-movement",signatures:"Amila Vujacic, Jasna Pavlovic and Aleksandra Konic-Ristic",dateSubmitted:"April 22nd 2018",dateReviewed:"July 9th 2018",datePrePublished:"November 9th 2018",datePublished:"April 10th 2019",book:{id:"7139",title:"Current Approaches in Orthodontics",subtitle:null,fullTitle:"Current Approaches in Orthodontics",slug:"current-approaches-in-orthodontics",publishedDate:"April 10th 2019",bookSignature:"Belma Işık Aslan and Fatma Deniz Uzuner",coverURL:"https://cdn.intechopen.com/books/images_new/7139.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"42847",title:"Dr.",name:"Belma",middleName:null,surname:"Işık Aslan",slug:"belma-isik-aslan",fullName:"Belma Işık Aslan"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"255738",title:"Associate Prof.",name:"Amila",middleName:null,surname:"Vujacic",fullName:"Amila Vujacic",slug:"amila-vujacic",email:"amilavujacic@gmail.com",position:null,institution:null},{id:"264430",title:"Prof.",name:"Jasna",middleName:null,surname:"Pavlovic",fullName:"Jasna Pavlovic",slug:"jasna-pavlovic",email:"drjasnapavlovic@gmail.com",position:null,institution:null},{id:"264432",title:"Dr.",name:"Aleksandra",middleName:null,surname:"Konic",fullName:"Aleksandra Konic",slug:"aleksandra-konic",email:"sandrakonic@gmail.com",position:null,institution:null}]},book:{id:"7139",title:"Current Approaches in Orthodontics",subtitle:null,fullTitle:"Current Approaches in Orthodontics",slug:"current-approaches-in-orthodontics",publishedDate:"April 10th 2019",bookSignature:"Belma Işık Aslan and Fatma Deniz Uzuner",coverURL:"https://cdn.intechopen.com/books/images_new/7139.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"42847",title:"Dr.",name:"Belma",middleName:null,surname:"Işık Aslan",slug:"belma-isik-aslan",fullName:"Belma Işık Aslan"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"8676",leadTitle:null,title:"Hip Surgeries",subtitle:null,reviewType:"peer-reviewed",abstract:"Hip surgery became a benchmark for large joint surgery development. Surgical techniques for the treatment of degenerative, developmental, and traumatic hip pathologies became a challenge, aiming to restore the patients' ambulation in otherwise disabling pathological conditions of the hip joint. In this book the authors present an overview of the pathological basis of the diseased hip and the currently available surgical solutions that provide long-term relief using a reconstructing surgical approach.The book aims to expose young orthopedic surgeons to exciting and continuously developing information on hip surgery, and experienced colleagues will benefit from concise information that might be beneficial in routine surgical activity.",isbn:"978-1-83880-236-3",printIsbn:"978-1-83880-235-6",pdfIsbn:"978-1-83962-148-2",doi:"10.5772/intechopen.80059",price:119,priceEur:129,priceUsd:155,slug:"hip-surgeries",numberOfPages:112,isOpenForSubmission:!1,hash:"35280afd3082f1a6b3c10bdc0ae447f6",bookSignature:"Nahum Rosenberg",publishedDate:"April 24th 2019",coverURL:"https://cdn.intechopen.com/books/images_new/8676.jpg",keywords:null,numberOfDownloads:1770,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"July 12th 2018",dateEndSecondStepPublish:"September 25th 2018",dateEndThirdStepPublish:"November 24th 2018",dateEndFourthStepPublish:"February 12th 2019",dateEndFifthStepPublish:"April 13th 2019",remainingDaysToSecondStep:"2 years",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"68911",title:"Dr.",name:"Nahum",middleName:null,surname:"Rosenberg",slug:"nahum-rosenberg",fullName:"Nahum Rosenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/68911/images/system/68911.png",biography:"Rosenberg Nahum MD, MOrth (Hons.), FRCS (England) is an orthopedic surgeon holding MD degree from Technion – ITT in 1990. \r\nHe did a residency in Orthopedic Surgery in Rambam Medical Center, Haifa between 1990-97. MOrth, Nuffield Fellow (Orthopedic Surgery) in Oxford University in 1998-9, fellowship in Orthopedic Surgery in University of Nottingham – 2002. \r\nHe is a senior orthopedic surgeon in Rambam Health Care Campus since 2003 and an Assistant Clinical Professor in the Faculty of Medicine, Technion -ITT, Haifa since 2007. \r\nHe is a member of editorial boards in 8 scientific journals. His research interests include the outcome of orthopedic procedures and bone biology.",institutionString:"I.M. Sechenov First Moscow State Medical University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Tel Aviv Sourasky Medical Center",institutionURL:null,country:{name:"Israel"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1150",title:"Orthopedics",slug:"orthopedics"}],chapters:[{id:"66211",title:"Introductory Chapter: Hip Surgeries",slug:"introductory-chapter-hip-surgeries",totalDownloads:256,totalCrossrefCites:0,authors:[{id:"68911",title:"Dr.",name:"Nahum",surname:"Rosenberg",slug:"nahum-rosenberg",fullName:"Nahum Rosenberg"}]},{id:"64894",title:"Osteoarthritis of the Hip Joint",slug:"osteoarthritis-of-the-hip-joint",totalDownloads:441,totalCrossrefCites:0,authors:[null]},{id:"64333",title:"Contemporary Non-Surgical Considerations in the Management of People with Extra- and Intra-Articular Hip Pathologies",slug:"contemporary-non-surgical-considerations-in-the-management-of-people-with-extra-and-intra-articular-",totalDownloads:405,totalCrossrefCites:0,authors:[null]},{id:"66227",title:"Hip Arthroplasty",slug:"hip-arthroplasty-1",totalDownloads:356,totalCrossrefCites:0,authors:[null]},{id:"64308",title:"Arthroplasty as a Choice of Treatment in Hip Surgery",slug:"arthroplasty-as-a-choice-of-treatment-in-hip-surgery",totalDownloads:312,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"194667",firstName:"Marijana",lastName:"Francetic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/194667/images/4752_n.jpg",email:"marijana@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"938",title:"Recent Advances in Arthroplasty",subtitle:null,isOpenForSubmission:!1,hash:"617e868a5450ec0c9d233121177ca61e",slug:"recent-advances-in-arthroplasty",bookSignature:"Samo K. Fokter",coverURL:"https://cdn.intechopen.com/books/images_new/938.jpg",editedByType:"Edited by",editors:[{id:"68181",title:"Dr.",name:"Samo",surname:"Fokter",slug:"samo-fokter",fullName:"Samo Fokter"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3394",title:"Arthroplasty",subtitle:"Update",isOpenForSubmission:!1,hash:"672aa53986638f5846f76ee8c8a1ea9e",slug:"arthroplasty-update",bookSignature:"Plamen Kinov",coverURL:"https://cdn.intechopen.com/books/images_new/3394.jpg",editedByType:"Edited by",editors:[{id:"64690",title:"Prof.",name:"Plamen",surname:"Kinov",slug:"plamen-kinov",fullName:"Plamen Kinov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2088",title:"Recent Advances in Scoliosis",subtitle:null,isOpenForSubmission:!1,hash:"83cd4ebc741a8c3eb6dd08e5a6957181",slug:"recent-advances-in-scoliosis",bookSignature:"Theodoros B. Grivas",coverURL:"https://cdn.intechopen.com/books/images_new/2088.jpg",editedByType:"Edited by",editors:[{id:"35180",title:"Dr.",name:"Theodoros",surname:"Grivas",slug:"theodoros-grivas",fullName:"Theodoros Grivas"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5164",title:"Advanced Techniques in Bone Regeneration",subtitle:null,isOpenForSubmission:!1,hash:"e99f852544eefac23fb5fe0697c2096d",slug:"advanced-techniques-in-bone-regeneration",bookSignature:"Alessandro Rozim Zorzi and Joao Batista de Miranda",coverURL:"https://cdn.intechopen.com/books/images_new/5164.jpg",editedByType:"Edited by",editors:[{id:"80871",title:"M.D.",name:"Alessandro Rozim",surname:"Zorzi",slug:"alessandro-rozim-zorzi",fullName:"Alessandro Rozim Zorzi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2012",title:"Recent Advances in Hip and Knee Arthroplasty",subtitle:null,isOpenForSubmission:!1,hash:"20ffb4ff9f89a7537b335291c94cda13",slug:"recent-advances-in-hip-and-knee-arthroplasty",bookSignature:"Samo K. Fokter",coverURL:"https://cdn.intechopen.com/books/images_new/2012.jpg",editedByType:"Edited by",editors:[{id:"68181",title:"Dr.",name:"Samo",surname:"Fokter",slug:"samo-fokter",fullName:"Samo Fokter"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"535",title:"Achilles Tendon",subtitle:null,isOpenForSubmission:!1,hash:"afb551afd8adf63d63a7c0a2b9513652",slug:"achilles-tendon",bookSignature:"Andrej Čretnik",coverURL:"https://cdn.intechopen.com/books/images_new/535.jpg",editedByType:"Edited by",editors:[{id:"91518",title:"Prof.",name:"Andrej",surname:"Cretnik",slug:"andrej-cretnik",fullName:"Andrej Cretnik"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"640",title:"Modern Arthroscopy",subtitle:null,isOpenForSubmission:!1,hash:"ad9afcdcfadbb0f3150016589356d633",slug:"modern-arthroscopy",bookSignature:"Jason L. Dragoo",coverURL:"https://cdn.intechopen.com/books/images_new/640.jpg",editedByType:"Edited by",editors:[{id:"77223",title:"Dr",name:"Jason L.",surname:"Dragoo",slug:"jason-l.-dragoo",fullName:"Jason L. Dragoo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5724",title:"Frailty and Sarcopenia",subtitle:"Onset, Development and Clinical Challenges",isOpenForSubmission:!1,hash:"3bddbdef3183cb7745a66525d1f93515",slug:"frailty-and-sarcopenia-onset-development-and-clinical-challenges",bookSignature:"Yannis Dionyssiotis",coverURL:"https://cdn.intechopen.com/books/images_new/5724.jpg",editedByType:"Edited by",editors:[{id:"76883",title:"PhD.",name:"Yannis",surname:"Dionyssiotis",slug:"yannis-dionyssiotis",fullName:"Yannis Dionyssiotis"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"756",title:"Orthopedic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"e33b92ab0447186525dd0440e3f03606",slug:"orthopedic-surgery",bookSignature:"Zaid Al-Aubaidi and Andreas Fette",coverURL:"https://cdn.intechopen.com/books/images_new/756.jpg",editedByType:"Edited by",editors:[{id:"63333",title:"Dr",name:"Zaid",surname:"Al-Aubaidi",slug:"zaid-al-aubaidi",fullName:"Zaid Al-Aubaidi"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5228",title:"Pain Management",subtitle:null,isOpenForSubmission:!1,hash:"fff27606077f643a636f40d3bff7757b",slug:"pain-management",bookSignature:"Milica Prostran",coverURL:"https://cdn.intechopen.com/books/images_new/5228.jpg",editedByType:"Edited by",editors:[{id:"43919",title:"Prof.",name:"Milica",surname:"Prostran",slug:"milica-prostran",fullName:"Milica Prostran"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"26062",title:"Infectious Complications of Anti-Tumour Necrosis Factor-α Therapy in Rheumatoid Arthritis",doi:"10.5772/27048",slug:"infectious-complications-of-anti-tumour-necrosis-factor-therapy-in-rheumatoid-arthritis",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/26062.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/26062",previewPdfUrl:"/chapter/pdf-preview/26062",totalDownloads:1468,totalViews:72,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,dateSubmitted:"February 15th 2011",dateReviewed:"September 21st 2011",datePrePublished:null,datePublished:"January 13th 2012",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/26062",risUrl:"/chapter/ris/26062",book:{slug:"insights-and-perspectives-in-rheumatology"},signatures:"Ioannis D. Xynos and Nikolaos V. Sipsas",authors:[{id:"68672",title:"Dr.",name:"Nicolaos",middleName:"V",surname:"Sipsas",fullName:"Nicolaos Sipsas",slug:"nicolaos-sipsas",email:"nsipsas@med.uoa.gr",position:null,institution:null},{id:"132770",title:"Dr.",name:"Ioannis",middleName:null,surname:"Xynos",fullName:"Ioannis Xynos",slug:"ioannis-xynos",email:"xynosid@gmail.com",position:null,institution:null}],sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"794",title:"Insights and Perspectives in Rheumatology",subtitle:null,fullTitle:"Insights and Perspectives in Rheumatology",slug:"insights-and-perspectives-in-rheumatology",publishedDate:"January 13th 2012",bookSignature:"Andrew Harrsion",coverURL:"https://cdn.intechopen.com/books/images_new/794.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"126484",title:"Associate Prof.",name:"Andrew",middleName:null,surname:"Harrison",slug:"andrew-harrison",fullName:"Andrew Harrison"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"26057",title:"Natural and Pathologic Autoantibodies",slug:"natural-and-pathologic-autoantibodies",totalDownloads:1391,totalCrossrefCites:0,signatures:"Péter Németh and Diána Simon",authors:[{id:"67481",title:"Prof.",name:"Peter",middleName:null,surname:"Nemeth",fullName:"Peter Nemeth",slug:"peter-nemeth"},{id:"67498",title:"Dr.",name:"Diana",middleName:null,surname:"Simon",fullName:"Diana Simon",slug:"diana-simon"}]},{id:"26058",title:"Adipokines and Systemic Rheumatic Diseases: Linking Inflammation, Immunity and Metabolism",slug:"adipokines-and-systemic-rheumatic-diseases-linking-inflammation-immunity-and-metabolism",totalDownloads:1904,totalCrossrefCites:0,signatures:"Morena Scotece, Javier Conde, Veronica Lopez, Rodolfo Gómez, Francisca Lago, Juan J Gómez Reino and Oreste Gualillo",authors:[{id:"25655",title:"Dr.",name:"Oreste",middleName:null,surname:"Gualillo",fullName:"Oreste Gualillo",slug:"oreste-gualillo"},{id:"34695",title:"Dr.",name:"Francisca",middleName:null,surname:"Lago",fullName:"Francisca Lago",slug:"francisca-lago"},{id:"34697",title:"Dr.",name:"Rodolfo",middleName:null,surname:"Gomez",fullName:"Rodolfo Gomez",slug:"rodolfo-gomez"},{id:"72030",title:"Ms.",name:"Morena",middleName:null,surname:"Scotece",fullName:"Morena Scotece",slug:"morena-scotece"},{id:"72050",title:"BSc.",name:"Javier",middleName:null,surname:"Conde",fullName:"Javier Conde",slug:"javier-conde"},{id:"72069",title:"Prof.",name:"Juan J",middleName:null,surname:"Gomez Reino",fullName:"Juan J Gomez Reino",slug:"juan-j-gomez-reino"},{id:"121141",title:"Mrs.",name:"Veronica",middleName:null,surname:"Lopez",fullName:"Veronica Lopez",slug:"veronica-lopez"}]},{id:"26059",title:"Gene Expression Profiling in Rheumatoid Arthritis",slug:"gene-expression-profiling-in-rheumatoid-arthritis",totalDownloads:2061,totalCrossrefCites:0,signatures:"Cornelis L. Verweij and Saskia Vosslamber",authors:[{id:"68659",title:"Prof.",name:"Cornelis",middleName:null,surname:"Verweij",fullName:"Cornelis Verweij",slug:"cornelis-verweij"}]},{id:"26060",title:"Vitamin D and Autoimmune Disease",slug:"vitamin-d-and-autoimmune-disease",totalDownloads:2615,totalCrossrefCites:0,signatures:"Ayah M. Boudal and Suzan M. Attar",authors:[{id:"68319",title:"Dr",name:"Suzan",middleName:"M",surname:"Attar",fullName:"Suzan Attar",slug:"suzan-attar"}]},{id:"26061",title:"Osteoporosis in Rheumatoid Arthritis",slug:"osteoporosis-in-rheumatoid-arthritis",totalDownloads:3512,totalCrossrefCites:1,signatures:"Alessandro Geraci",authors:[{id:"65437",title:"Prof.",name:"Alessandro",middleName:null,surname:"Geraci",fullName:"Alessandro Geraci",slug:"alessandro-geraci"}]},{id:"26062",title:"Infectious Complications of Anti-Tumour Necrosis Factor-α Therapy in Rheumatoid Arthritis",slug:"infectious-complications-of-anti-tumour-necrosis-factor-therapy-in-rheumatoid-arthritis",totalDownloads:1468,totalCrossrefCites:0,signatures:"Ioannis D. Xynos and Nikolaos V. Sipsas",authors:[{id:"68672",title:"Dr.",name:"Nicolaos",middleName:"V",surname:"Sipsas",fullName:"Nicolaos Sipsas",slug:"nicolaos-sipsas"},{id:"132770",title:"Dr.",name:"Ioannis",middleName:null,surname:"Xynos",fullName:"Ioannis Xynos",slug:"ioannis-xynos"}]},{id:"26063",title:"Pamidronate Treatment in Charcot Neuro-Osteoarthropathy: Change in Biochemical Markers of Bone Turnover and Radiographic Outcome After Treatment",slug:"pamidronate-treatment-in-charcot-neuro-osteoarthropathy-change-in-biochemical-markers-of-bone-turnov",totalDownloads:1682,totalCrossrefCites:0,signatures:"Ivonne Vázquez, Mireia Moreno and Marta Larrosa",authors:[{id:"64992",title:"Dr.",name:"Ivonne",middleName:null,surname:"Vazquez",fullName:"Ivonne Vazquez",slug:"ivonne-vazquez"},{id:"72334",title:"Dr.",name:"Mireia",middleName:null,surname:"Moreno",fullName:"Mireia Moreno",slug:"mireia-moreno"},{id:"72376",title:"Dr.",name:"Marta",middleName:null,surname:"Larrosa",fullName:"Marta Larrosa",slug:"marta-larrosa"},{id:"72378",title:"Dr.",name:"Jordi",middleName:null,surname:"Gratacos",fullName:"Jordi Gratacos",slug:"jordi-gratacos"}]},{id:"26064",title:"Diagnostic and Prognostic Features of Sjögren’s Syndrome",slug:"diagnostic-and-prognostic-features-of-sjo-gren-s-syndrome",totalDownloads:8846,totalCrossrefCites:0,signatures:"Muhammad S. Soyfoo and Elie Cogan",authors:[{id:"51556",title:"Dr",name:"Muhammad",middleName:"Shahnawaz",surname:"Soyfoo",fullName:"Muhammad Soyfoo",slug:"muhammad-soyfoo"},{id:"119949",title:"Prof.",name:"Elie",middleName:null,surname:"Cogan",fullName:"Elie Cogan",slug:"elie-cogan"}]},{id:"26065",title:"Oral Aspects of Sjögren’s Syndrome",slug:"oral-aspects-of-sjo-gren-s-syndrome",totalDownloads:3077,totalCrossrefCites:1,signatures:"Sertan Ergun",authors:[{id:"66225",title:"Dr.",name:"Sertan",middleName:null,surname:"Ergun",fullName:"Sertan Ergun",slug:"sertan-ergun"}]},{id:"26066",title:"Mechanisms of Salivary Gland Secretory Dysfunction in Sjögren’s Syndrome",slug:"mechanisms-of-salivary-gland-secretory-dysfunction-in-sjo-gren-s-syndrome",totalDownloads:2235,totalCrossrefCites:0,signatures:"Kaleb M. Pauley, Byung Ha Lee, Adrienne E. Gauna and Seunghee Cha",authors:[{id:"73020",title:"Dr.",name:"Seunghee",middleName:null,surname:"Cha",fullName:"Seunghee Cha",slug:"seunghee-cha"},{id:"73026",title:"BSc",name:"Adrienne",middleName:null,surname:"Gauna",fullName:"Adrienne Gauna",slug:"adrienne-gauna"},{id:"73028",title:"Dr.",name:"Kaleb",middleName:null,surname:"Pauley",fullName:"Kaleb Pauley",slug:"kaleb-pauley"},{id:"118887",title:"Dr.",name:"Byungha",middleName:null,surname:"Lee",fullName:"Byungha Lee",slug:"byungha-lee"}]},{id:"26067",title:"Sjögren’s Syndrome: The Proteomic Approaches",slug:"sjo-gren-s-syndrome-the-proteomic-approaches",totalDownloads:1937,totalCrossrefCites:0,signatures:"Laura Giusti, Chiara Baldini, Laura Bazzichi, Stefano Bombardieri and Antonio Lucacchini",authors:[{id:"68471",title:"Prof.",name:"Antonio",middleName:null,surname:"Lucacchini",fullName:"Antonio Lucacchini",slug:"antonio-lucacchini"},{id:"68476",title:"Dr.",name:"Laura",middleName:null,surname:"Giusti",fullName:"Laura Giusti",slug:"laura-giusti"},{id:"142439",title:"Dr.",name:"Laura",middleName:null,surname:"Bazzichi",fullName:"Laura Bazzichi",slug:"laura-bazzichi"},{id:"147557",title:"Dr.",name:"Chiara",middleName:null,surname:"Baldini",fullName:"Chiara Baldini",slug:"chiara-baldini"},{id:"147558",title:"Dr.",name:"Stefano",middleName:null,surname:"Bombardieri",fullName:"Stefano Bombardieri",slug:"stefano-bombardieri"}]},{id:"26068",title:"The Pathogenetic Link Between Stress and Rheumatic Diseases",slug:"the-pathogenetic-link-between-stress-and-rheumatic-diseases",totalDownloads:1479,totalCrossrefCites:0,signatures:"O. Malysheva and C.G.O. Baerwald",authors:[{id:"65753",title:"Dr.",name:"Olga",middleName:null,surname:"Malysheva",fullName:"Olga Malysheva",slug:"olga-malysheva"}]},{id:"26069",title:"Pain in Rheumatic Diseases",slug:"pain-in-rheumatic-diseases",totalDownloads:3027,totalCrossrefCites:0,signatures:"Susette Unger and Christoph Baerwald",authors:[{id:"65255",title:"Prof.",name:"Christoph",middleName:null,surname:"Baerwald",fullName:"Christoph Baerwald",slug:"christoph-baerwald"},{id:"74647",title:"Dr.",name:"Susette",middleName:null,surname:"Unger",fullName:"Susette Unger",slug:"susette-unger"}]},{id:"26070",title:"Transition of Care in Rheumatology: Managing the Rheumatic Patient from Childhood to Adulthood",slug:"transition-of-care-in-rheumatology-managing-the-rheumatic-patient-from-childhood-to-adulthood",totalDownloads:1740,totalCrossrefCites:0,signatures:"Philomine van Pelt and Nico Wulffraat",authors:[{id:"75448",title:"Dr.",name:"Nico",middleName:null,surname:"Wulffraat",fullName:"Nico Wulffraat",slug:"nico-wulffraat"},{id:"75450",title:"Dr.",name:null,middleName:null,surname:"Van Pelt",fullName:"Van Pelt",slug:"van-pelt"}]}]},relatedBooks:[{type:"book",id:"758",title:"Osteoporosis",subtitle:null,isOpenForSubmission:!1,hash:"b52e42df6cd850721e557bedd3a4a77b",slug:"osteoporosis",bookSignature:"Yannis Dionyssiotis",coverURL:"https://cdn.intechopen.com/books/images_new/758.jpg",editedByType:"Edited by",editors:[{id:"76883",title:"PhD.",name:"Yannis",surname:"Dionyssiotis",slug:"yannis-dionyssiotis",fullName:"Yannis Dionyssiotis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"29534",title:"Bone Mineral Quality",slug:"bone-mineral-quality",signatures:"Delphine Farlay and Georges Boivin",authors:[{id:"76470",title:"Dr.",name:"Delphine",middleName:null,surname:"Farlay",fullName:"Delphine Farlay",slug:"delphine-farlay"},{id:"86702",title:"Dr.",name:"Georges",middleName:null,surname:"Boivin",fullName:"Georges Boivin",slug:"georges-boivin"}]},{id:"29535",title:"Genetics and Osteoporosis",slug:"genetics-and-osteoporosis",signatures:"Margarita Valdés-Flores, Leonora Casas-Avila, Valeria Ponce de León-Suárez and Edith Falcón-Ramírez",authors:[{id:"76697",title:"Dr.",name:"Margarita",middleName:null,surname:"Valdés-Flores",fullName:"Margarita Valdés-Flores",slug:"margarita-valdes-flores"},{id:"123726",title:"Dr.",name:"Leonora",middleName:null,surname:"Casas-Avila",fullName:"Leonora Casas-Avila",slug:"leonora-casas-avila"},{id:"123732",title:"Dr.",name:"Edith",middleName:null,surname:"Falcón-Ramírez",fullName:"Edith Falcón-Ramírez",slug:"edith-falcon-ramirez"},{id:"123741",title:"Dr.",name:"Valeria",middleName:null,surname:"Ponce De León Suárez",fullName:"Valeria Ponce De León Suárez",slug:"valeria-ponce-de-leon-suarez"}]},{id:"29536",title:"Biomechanics of Osteoporosis: The Importance of Bone Resorption and Remodeling Processes",slug:"biomechanics-of-osteoporosis-the-importance-of-bone-resorption-and-remodeling-processes",signatures:"Gholamreza Rouhi",authors:[{id:"2360",title:"Dr.",name:"Gholamreza",middleName:null,surname:"Rouhi",fullName:"Gholamreza Rouhi",slug:"gholamreza-rouhi"}]},{id:"29537",title:"Self-Reported Prevalence of Osteoporosis in Australia",slug:"self-reported-prevalence-of-osteoporosis-in-australia",signatures:"Tiffany K. Gill, Anne W. Taylor, Julie Black and Catherine L. Hill",authors:[{id:"83848",title:"Dr.",name:"Tiffany",middleName:"Kaye",surname:"Gill",fullName:"Tiffany Gill",slug:"tiffany-gill"},{id:"83849",title:"Dr.",name:"Anne",middleName:null,surname:"Taylor",fullName:"Anne Taylor",slug:"anne-taylor"},{id:"86995",title:"Mrs",name:"Julie",middleName:"Ann",surname:"Black",fullName:"Julie Black",slug:"julie-black"},{id:"86996",title:"Dr.",name:"Catherine",middleName:null,surname:"Hill",fullName:"Catherine Hill",slug:"catherine-hill"}]},{id:"29538",title:"Prevalence of Back Pain in Postmenopausal Osteoporosis and Associations with Multiple Spinal Factors",slug:"prevalence-of-back-pain-in-postmenopausal-osteoporosis-and-associations-with-multiple-spinal-factors",signatures:"Naohisa Miyakoshi, Michio Hongo and Yoichi Shimada",authors:[{id:"84172",title:"Dr.",name:"Naohisa",middleName:null,surname:"Miyakoshi",fullName:"Naohisa Miyakoshi",slug:"naohisa-miyakoshi"},{id:"111551",title:"Dr.",name:"Michio",middleName:null,surname:"Hongo",fullName:"Michio Hongo",slug:"michio-hongo"},{id:"111552",title:"Dr.",name:"Yoichi",middleName:null,surname:"Shimada",fullName:"Yoichi Shimada",slug:"yoichi-shimada"}]},{id:"29539",title:"The Diagnosis and Workup of Patients for Osteoporosis or Osteopenia (Low Bone Mass)",slug:"the-diagnosis-and-workup-of-patients-for-osteoporosis-or-osteopenia-low-bone-mass-",signatures:"Frank Bonura",authors:[{id:"88299",title:"Dr",name:"Frank",middleName:null,surname:"Bonura",fullName:"Frank Bonura",slug:"frank-bonura"}]},{id:"29540",title:"Evolutionary Pathways of Diagnosis in Osteoporosis",slug:"evolutionary-pathways-of-diagnosis-in-osteoporosis",signatures:"Antonio Bazarra-Fernández",authors:[{id:"77689",title:"Dr.",name:"Antonio",middleName:null,surname:"Bazarra-Fernandez",fullName:"Antonio Bazarra-Fernandez",slug:"antonio-bazarra-fernandez"}]},{id:"29541",title:"Approach to the Screening and Diagnosis of Osteoporosis",slug:"approach-to-the-screening-and-diagnosis-of-osteoporosis",signatures:"Choi H.J.",authors:[{id:"85702",title:"Prof.",name:"Hee Jeong",middleName:null,surname:"Choi",fullName:"Hee Jeong Choi",slug:"hee-jeong-choi"}]},{id:"29542",title:"Early Detection Techniques for Osteoporosis",slug:"early-detection-techniques-for-osteoporosis",signatures:"Kanika Singh and Kyung Chun Kim",authors:[{id:"79379",title:"Prof.",name:"Kyung Chun",middleName:null,surname:"Kim",fullName:"Kyung Chun Kim",slug:"kyung-chun-kim"},{id:"86022",title:"Dr.",name:"Kanika",middleName:null,surname:"Singh",fullName:"Kanika Singh",slug:"kanika-singh"}]},{id:"29543",title:"Sophisticated Imaging Technology in the Assessment of Osteoporosis Risk",slug:"sophisticated-imaging-technology-in-the-assessment-of-osteoporosis-risk",signatures:"Huayue Chen, Tatsuro Hayashi, Xiangrong Zhou, Hiroshi Fujita, Minoru Onozuka and Kin-ya Kubo",authors:[{id:"76312",title:"Dr.",name:"Huayue",middleName:null,surname:"Chen",fullName:"Huayue Chen",slug:"huayue-chen"}]},{id:"29544",title:"What We Learn from Bone Complications in Congenital Diseases? Thalassemia, an Example",slug:"what-we-learn-from-bone-complications-in-congenital-diseases-thalassemia-an-example",signatures:"Zohreh Hamidi",authors:[{id:"82470",title:"Dr.",name:"Zohreh",middleName:null,surname:"Hamidi",fullName:"Zohreh Hamidi",slug:"zohreh-hamidi"}]},{id:"29545",title:"What's BMD and What We Do in a BMD Centre?",slug:"what-s-bmd-and-what-we-do-in-a-bmd-centre-",signatures:"Zohreh Hamidi",authors:[{id:"82470",title:"Dr.",name:"Zohreh",middleName:null,surname:"Hamidi",fullName:"Zohreh Hamidi",slug:"zohreh-hamidi"}]},{id:"29546",title:"Patchy Osteoporosis in Complex Regional Pain Syndrome",slug:"patchy-osteoporosis-in-complex-regional-pain-syndrome",signatures:"Geun-Young Park, Sun Im and Seong Hoon Lim",authors:[{id:"76786",title:"Dr.",name:"Geun-Young",middleName:null,surname:"Park",fullName:"Geun-Young Park",slug:"geun-young-park"},{id:"115818",title:"Dr.",name:"Sun",middleName:null,surname:"Im",fullName:"Sun Im",slug:"sun-im"},{id:"115819",title:"Dr.",name:"Seong Hoon",middleName:null,surname:"Lim",fullName:"Seong Hoon Lim",slug:"seong-hoon-lim"}]},{id:"29547",title:"Osteoporosis in Microgravity Environments",slug:"osteoporosis-in-microgravity-environments",signatures:"Bradley K. Weiner, Scott E. Parazynski and Ennio Tasciotti",authors:[{id:"75500",title:"Prof.",name:"Bradley",middleName:null,surname:"Weiner",fullName:"Bradley Weiner",slug:"bradley-weiner"}]},{id:"29548",title:"Neurological Osteoporosis in Disabilities",slug:"neurological-osteoporosis-in-disabilities",signatures:"Yannis Dionyssiotis",authors:[{id:"76883",title:"PhD.",name:"Yannis",middleName:null,surname:"Dionyssiotis",fullName:"Yannis Dionyssiotis",slug:"yannis-dionyssiotis"}]},{id:"29549",title:"Post-Transplantation Bone Disease",slug:"post-transplantation-bone-disease",signatures:"Federico G. Hawkins, Sonsoles Guadalix, Raquel Sanchez and Guillermo Martínez",authors:[{id:"78861",title:"Prof.",name:"Federico",middleName:null,surname:"Hawkins Carranza",fullName:"Federico Hawkins Carranza",slug:"federico-hawkins-carranza"}]},{id:"29550",title:"The Skeleton Abnormalities in Patients with Neurofibromatosis Type 1: Important Consequences of Abnormal Gene Function",slug:"the-skeleton-abnormalities-in-patients-with-neurofibromatosis-type-1-important-consequences-of-abnor",signatures:"Marek W. Karwacki and Wojciech Wozniak",authors:[{id:"86757",title:"Dr.",name:"Marek",middleName:"W.",surname:"Karwacki",fullName:"Marek Karwacki",slug:"marek-karwacki"}]},{id:"29551",title:"Studies of Osteoporosis in Cancer Patients in Slovakia – Experience from Single Institute",slug:"studies-of-osteoporosis-in-cancer-patients-in-slovakia-experience-from-single-institute",signatures:"Beata Spanikova and Stanislav Spanik",authors:[{id:"79511",title:"Dr",name:"Stanislav",middleName:null,surname:"Spanik",fullName:"Stanislav Spanik",slug:"stanislav-spanik"},{id:"123883",title:"Dr.",name:"Beata",middleName:null,surname:"Spanikova",fullName:"Beata Spanikova",slug:"beata-spanikova"}]},{id:"29552",title:"Osteoporosis in Pediatric Patients and Its Clinical Management",slug:"osteoporosis-in-pediatric-patients-and-its-clinical-management",signatures:"Emilio González Jiménez",authors:[{id:"77001",title:"Dr.",name:"Emilio",middleName:null,surname:"González-Jiménez",fullName:"Emilio González-Jiménez",slug:"emilio-gonzalez-jimenez"}]},{id:"29553",title:"Physical Activity Interactions with Bone Accrual in Children and Adolescents",slug:"physical-activity-interactions-with-bone-accrual-in-children-and-adolescents",signatures:"Izabella A. Ludwa and Panagiota Klentrou",authors:[{id:"82220",title:"Dr",name:"Panagiota",middleName:null,surname:"Klentrou",fullName:"Panagiota Klentrou",slug:"panagiota-klentrou"},{id:"87457",title:"MSc.",name:"Izabella",middleName:"Atena",surname:"Ludwa",fullName:"Izabella Ludwa",slug:"izabella-ludwa"}]},{id:"29554",title:"Osteoporosis, Nutrition and Adolescence",slug:"osteoporosis-nutrition-and-adolescence",signatures:"Isabel Seiquer, Marta Mesías and M. Pilar Navarro",authors:[{id:"79053",title:"Dr.",name:"Isabel",middleName:null,surname:"Seiquer",fullName:"Isabel Seiquer",slug:"isabel-seiquer"},{id:"85396",title:"Dr.",name:"Marta",middleName:null,surname:"Mesías",fullName:"Marta Mesías",slug:"marta-mesias"},{id:"85399",title:"Dr.",name:"María Pilar",middleName:null,surname:"Navarro",fullName:"María Pilar Navarro",slug:"maria-pilar-navarro"}]},{id:"29555",title:"Rehabilitation in Osteoporosis",slug:"rehabilitation-in-osteoporosis",signatures:"Yannis Dionyssiotis",authors:[{id:"76883",title:"PhD.",name:"Yannis",middleName:null,surname:"Dionyssiotis",fullName:"Yannis Dionyssiotis",slug:"yannis-dionyssiotis"}]},{id:"29556",title:"Physical Exercise for Prevention of Falls and Fractures",slug:"physical-exercise-for-prevention-of-falls-and-fractures",signatures:"Lucas Teixeira, Joelma Magalhães, Stella Peccin, Rebeca Teixeira, Kelson Silva, Tiago Teixeira, Jander Souza and Virgínia Trevisani",authors:[{id:"63890",title:"MSc.",name:"Kelson",middleName:null,surname:"Silva",fullName:"Kelson Silva",slug:"kelson-silva"},{id:"75687",title:"PhD.",name:"Lucas",middleName:"Emmanuel",surname:"Teixeira",fullName:"Lucas Teixeira",slug:"lucas-teixeira"},{id:"80042",title:"Dr.",name:"Virginia",middleName:null,surname:"Trevisani",fullName:"Virginia Trevisani",slug:"virginia-trevisani"},{id:"80044",title:"Dr.",name:"Tiago",middleName:"Jose De Paiva",surname:"Teixeira",fullName:"Tiago Teixeira",slug:"tiago-teixeira"},{id:"80045",title:"MSc.",name:"Joelma",middleName:null,surname:"Magalhães",fullName:"Joelma Magalhães",slug:"joelma-magalhaes"},{id:"80049",title:"Ms.",name:"Rebeca",middleName:null,surname:"Teixeira",fullName:"Rebeca Teixeira",slug:"rebeca-teixeira"},{id:"122997",title:"Dr.",name:"Stella",middleName:null,surname:"Peccin",fullName:"Stella Peccin",slug:"stella-peccin"},{id:"127780",title:"Mr.",name:"Jander",middleName:null,surname:"Souza",fullName:"Jander Souza",slug:"jander-souza"}]},{id:"29557",title:"The Effect of Exercise on Bone Mineral Density, Bone Markers and Postural Stability in Subjects with Osteoporosis",slug:"the-effect-of-exercise-on-bone-mineral-density-bone-markers-and-postural-stability-in-subjects-with-",signatures:"M. Janura, Z. Krhutová, Z. Svoboda and P. Novosad",authors:[{id:"79364",title:"Prof.",name:"Miroslav",middleName:null,surname:"Janura",fullName:"Miroslav Janura",slug:"miroslav-janura"},{id:"87209",title:"Dr.",name:"Zdenek",middleName:null,surname:"Svoboda",fullName:"Zdenek Svoboda",slug:"zdenek-svoboda"},{id:"87215",title:"Dr.",name:"Zdeňka",middleName:null,surname:"Krhutová",fullName:"Zdeňka Krhutová",slug:"zdenka-krhutova"},{id:"87230",title:"Dr.",name:"Pavel",middleName:null,surname:"Novosad",fullName:"Pavel Novosad",slug:"pavel-novosad"}]},{id:"29558",title:"Impaired Ability to Perform the Sit-to-Stand Task in Osteoporotic Women",slug:"impaired-ability-to-perform-the-sit-to-stand-task-in-osteoporotic-women",signatures:"Deborah Colucci Trevisan, Francisco José Albuquerque de Paula, Júlia Guimarães Reis, Gustavo de Carvalho da Costa and Daniela Cristina Carvalho de Abreu",authors:[{id:"79420",title:"Dr.",name:"Daniela",middleName:"Cristina Carvalho De",surname:"Abreu",fullName:"Daniela Abreu",slug:"daniela-abreu"},{id:"79477",title:"MSc.",name:"Deborah",middleName:null,surname:"Trevisan",fullName:"Deborah Trevisan",slug:"deborah-trevisan"},{id:"79479",title:"MSc.",name:"Julia",middleName:null,surname:"Reis",fullName:"Julia Reis",slug:"julia-reis"},{id:"79480",title:"MSc.",name:"Gustavo",middleName:null,surname:"Costa",fullName:"Gustavo Costa",slug:"gustavo-costa"},{id:"79481",title:"Prof.",name:"Francisco José",middleName:null,surname:"Paula",fullName:"Francisco José Paula",slug:"francisco-jose-paula"}]},{id:"29559",title:"Osteoporosis and Arterial Stiffness: Effects of Exercise Training",slug:"osteoporosis-and-arterial-stiffness-effects-of-exercise-training",signatures:"Takanobu Okamoto",authors:[{id:"78665",title:"Dr.",name:"Takanobu",middleName:null,surname:"Okamoto",fullName:"Takanobu Okamoto",slug:"takanobu-okamoto"}]},{id:"29560",title:"Osteoporotic Pain",slug:"osteoporotic-pain",signatures:"Sumihisa Orita, Seiji Ohtori, Gen Inoue and Kazuhisa Takahashi",authors:[{id:"78952",title:"Dr.",name:"Sumihisa",middleName:null,surname:"Orita",fullName:"Sumihisa Orita",slug:"sumihisa-orita"},{id:"96524",title:"Dr.",name:"Seiji",middleName:null,surname:"Ohtori",fullName:"Seiji Ohtori",slug:"seiji-ohtori"},{id:"96525",title:"Prof.",name:"Kazuhisa",middleName:null,surname:"Takahashi",fullName:"Kazuhisa Takahashi",slug:"kazuhisa-takahashi"},{id:"126366",title:"Dr.",name:"Gen",middleName:null,surname:"Inoue",fullName:"Gen Inoue",slug:"gen-inoue"}]},{id:"29561",title:"Pharmacological Treatment of Osteoporosis",slug:"pharmacological-treatment-of-osteoporosis",signatures:"Jorge Malouf-Sierra and Roberto Güerri-Fernández",authors:[{id:"83037",title:"Dr.",name:"Jorge",middleName:null,surname:"Malouf Sierra",fullName:"Jorge Malouf Sierra",slug:"jorge-malouf-sierra"},{id:"118982",title:"Dr.",name:"Robert",middleName:null,surname:"Güerri-Fernández",fullName:"Robert Güerri-Fernández",slug:"robert-guerri-fernandez"}]},{id:"29562",title:"The Role of Hormone Replacement Therapy (HRT) and Tibolone in the Prevention and Treatment of Postmenopausal Osteoporosis",slug:"the-role-of-hormone-replacement-therapy-hrt-and-tibolone-in-the-prevention-and-treatment-of-postmeno",signatures:"Marta Lamarca",authors:[{id:"81148",title:"Dr.",name:"Marta",middleName:null,surname:"Lamarca",fullName:"Marta Lamarca",slug:"marta-lamarca"}]},{id:"29563",title:"Osteonecrosis of the Jaw Involving Bisphosphonate Treatment for Osteoporosis",slug:"osteonecrosis-of-the-jaw-involving-bisphosphonate-treatment-for-osteoporosis",signatures:"Maria Panaś, Małgorzata Zaleska and Tomasz Kaczmarzyk",authors:[{id:"85541",title:"Dr",name:"Maria",middleName:null,surname:"Panaś",fullName:"Maria Panaś",slug:"maria-panas"},{id:"122594",title:"Dr.",name:"Małgorzata",middleName:null,surname:"Zaleska",fullName:"Małgorzata Zaleska",slug:"malgorzata-zaleska"},{id:"122595",title:"Dr.",name:"Tomasz",middleName:null,surname:"Kaczmarzyk",fullName:"Tomasz Kaczmarzyk",slug:"tomasz-kaczmarzyk"}]},{id:"29564",title:"Balloon Kyphoplasty for Osteoporosis: Technical Notes",slug:"balloon-kyphoplasty-for-osteoporosis-technical-notes",signatures:"Antoine Nachanakian, Antonios El Helou, Sami Salem and Moussa Alaywan",authors:[{id:"116842",title:"Prof.",name:"Antoine",middleName:null,surname:"Nachanakian",fullName:"Antoine Nachanakian",slug:"antoine-nachanakian"},{id:"117443",title:"Dr.",name:"Antonios",middleName:"Georges",surname:"El Helou",fullName:"Antonios El Helou",slug:"antonios-el-helou"},{id:"117444",title:"Dr.",name:"Sami",middleName:null,surname:"Salem",fullName:"Sami Salem",slug:"sami-salem"},{id:"117445",title:"Dr.",name:"Moussa",middleName:null,surname:"Alaywan",fullName:"Moussa Alaywan",slug:"moussa-alaywan"}]},{id:"29565",title:"Minimally Invasive Treatment of Vertebral Body Fractures",slug:"minimally-invasive-treatment-of-vertebral-body-fractures",signatures:"Pasquale De Negri and Tiziana Tirri",authors:[{id:"75553",title:"Dr.",name:"Pasquale",middleName:null,surname:"De Negri",fullName:"Pasquale De Negri",slug:"pasquale-de-negri"},{id:"85148",title:"Dr.",name:"Tiziana",middleName:null,surname:"Tirri",fullName:"Tiziana Tirri",slug:"tiziana-tirri"}]},{id:"29566",title:"Osteoporosis: A Look at the Future",slug:"osteoporosis-a-look-at-the-future",signatures:"Iliyan Kolev, Lyudmila Ivanova, Leni Markova, Anelia Dimitrova, Cyril Popov and Margarita D. Apostolova",authors:[{id:"75527",title:"Dr.",name:"Margarita",middleName:"Dimitrova",surname:"Apostolova",fullName:"Margarita Apostolova",slug:"margarita-apostolova"},{id:"86282",title:"MSc.",name:"Iliyan",middleName:null,surname:"Kolev",fullName:"Iliyan Kolev",slug:"iliyan-kolev"},{id:"86283",title:"MSc.",name:"Lyudmila",middleName:null,surname:"Ivanova",fullName:"Lyudmila Ivanova",slug:"lyudmila-ivanova"},{id:"86284",title:"Mrs.",name:"Leni",middleName:null,surname:"Markova",fullName:"Leni Markova",slug:"leni-markova"},{id:"86286",title:"Prof.",name:"Anelia",middleName:"Aleksandrova",surname:"Dimitrova",fullName:"Anelia Dimitrova",slug:"anelia-dimitrova"},{id:"86289",title:"Prof.",name:"Cyril",middleName:null,surname:"Popov",fullName:"Cyril Popov",slug:"cyril-popov"}]},{id:"29567",title:"Simulating Bone Atrophy and Its Effects on the Structure and Stability of the Trabecular Bone",slug:"simulating-bone-atrophy-and-its-effects-on-the-structure-and-stability-of-the-trabecular-bone",signatures:"Christoph Räth, Irina Sidorenko, Roberto Monetti, Jan Bauer, Thomas Baum, Maiko Matsuura, Philippe Zysset and Felix Eckstein",authors:[{id:"56283",title:"Dr.",name:"Christoph",middleName:null,surname:"Räth",fullName:"Christoph Räth",slug:"christoph-rath"}]},{id:"29568",title:"Role of Phytoestrogen Ferutinin in Preventing/Recovering Bone Loss: Results from Experimental Ovariectomized Rat Models",slug:"role-of-phytoestrogen-ferutinin-in-preventing-recovering-bone-loss-results-from-experimental-ovariec",signatures:"Carla Palumbo, Francesco Cavani, Laura Bertoni and Marzia Ferretti",authors:[{id:"75816",title:"Prof.",name:"Carla",middleName:null,surname:"Palumbo",fullName:"Carla Palumbo",slug:"carla-palumbo"},{id:"84964",title:"Prof.",name:"Marzia",middleName:null,surname:"Ferretti",fullName:"Marzia Ferretti",slug:"marzia-ferretti"},{id:"84968",title:"Dr.",name:"Francesco",middleName:null,surname:"Cavani",fullName:"Francesco Cavani",slug:"francesco-cavani"},{id:"84970",title:"Dr.",name:"Laura",middleName:null,surname:"Bertoni",fullName:"Laura Bertoni",slug:"laura-bertoni"}]},{id:"29569",title:"The Phytoestrogens, Calcitonin and Thyroid Hormones: Effects on Bone Tissue",slug:"the-phytoestrogens-calcitonin-and-thyroid-hormones-effects-on-bone-tissue",signatures:"Branko Filipović and Branka Šošić-Jurjević",authors:[{id:"44958",title:"Dr.",name:"Branko",middleName:null,surname:"Filipovic",fullName:"Branko Filipovic",slug:"branko-filipovic"},{id:"85513",title:"Dr.",name:"Branka",middleName:null,surname:"Sosic-Jurjevic",fullName:"Branka Sosic-Jurjevic",slug:"branka-sosic-jurjevic"}]},{id:"29570",title:"Nutrition for Enhancing Bone Volume in Mice",slug:"nutrition-for-enhancing-bone-volume-in-mice",signatures:"Junji Ohtani, Fujita Tadashi, R.A. Marquez Hernandez, Toshitsugu Kawata, Masato Kaku, Masahide Motokawa and Kazuo Tanne",authors:[{id:"81412",title:"Dr.",name:"Junji",middleName:null,surname:"Ohtani",fullName:"Junji Ohtani",slug:"junji-ohtani"}]},{id:"29571",title:"Osteoporosis and Bone Regeneration",slug:"osteoporosis-and-bone-regeneration",signatures:"Shinji Kuroda, Kanako Noritake and Shohei Kasugai",authors:[{id:"61656",title:"Prof.",name:"Shohei",middleName:null,surname:"Kasugai",fullName:"Shohei Kasugai",slug:"shohei-kasugai"},{id:"84104",title:"Dr.",name:"Shinji",middleName:null,surname:"Kuroda",fullName:"Shinji Kuroda",slug:"shinji-kuroda"},{id:"90335",title:"Dr.",name:"Kanako",middleName:null,surname:"Noritake",fullName:"Kanako Noritake",slug:"kanako-noritake"}]},{id:"29572",title:"Lactoferrin – A Potential Anabolic Intervention in Osteoporosis",slug:"lactoferrin-a-potential-anabolic-intervention-in-osteoporosis",signatures:"Dorit Naot, Kate Palmano and Jillian Cornish",authors:[{id:"78754",title:"Prof.",name:"Jillian",middleName:null,surname:"Cornish",fullName:"Jillian Cornish",slug:"jillian-cornish"},{id:"84689",title:"Dr.",name:"Dorit",middleName:null,surname:"Naot",fullName:"Dorit Naot",slug:"dorit-naot"},{id:"84704",title:"Dr.",name:"Kate",middleName:null,surname:"Palmano",fullName:"Kate Palmano",slug:"kate-palmano"}]},{id:"29573",title:"How Dentistry Can Help Fight Osteoporosis",slug:"how-dentistry-can-help-fight-osteoporosis",signatures:"Plauto Christopher Aranha Watanabe, Marlivia Gonçalves de Carvalho Watanabe and Rodrigo Tiossi",authors:[{id:"76171",title:"Prof.",name:"Plauto C. A.",middleName:null,surname:"Watanabe",fullName:"Plauto C. A. Watanabe",slug:"plauto-c.-a.-watanabe"}]},{id:"29574",title:"Effect of Bisphosphonates on Root Growth and on Chlorophyll Formation in Arabidopsis thaliana Seedlings",slug:"effect-of-bisphosphonates-on-root-growth-and-on-chlorophyll-formation-in-arabidopsis-thaliana-seedli",signatures:"Ana I. Manzano, F. Javier Medina, Francisco J. Pérez-Zuñiga, Maria A. Günther Sillero and Antonio Sillero",authors:[{id:"81573",title:"Prof.",name:"Antonio",middleName:null,surname:"Sillero",fullName:"Antonio Sillero",slug:"antonio-sillero"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"69574",title:"Vitamin D Deficiency in Renal Disease",doi:"10.5772/intechopen.88928",slug:"vitamin-d-deficiency-in-renal-disease",body:'\n
Vitamin D (VD) deficiency is a growing problem worldwide [1]. Due to the wide distribution of the vitamin D receptor in human body, the effect of VD spans beyond calcium-phosphorus and bone metabolism—VD deficiency is associated with higher prevalence of hypertension, diabetes mellitus, and neoplasia [2]. As kidneys play an important role in the metabolism of VD, patients with chronic kidney disease (CKD) are at increased risk for VD deficiency. The aim of our chapter is to demonstrate the clinical implications of vitamin D deficiency in CKD and to outline the possible treatment options in this group of patients. In our review, a stress is laid on clinical trials due to their greater relevance to everyday clinical practice, compared to in vitro and animal models.
\nVD status is being evaluated via the serum level of 25-hydroxyvitamin D (25VD)—the metabolite formed in the first hydroxylation in the liver, due to its longer half-life (approx. 3 weeks), compared to the active metabolite 1,25-dihydroxyvitamin D (1,25VD) (4–6 hours). The best options for 25VD serum level evaluation methods are high performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). There are reports, discussing the use of free 25VD as indicator of VD status. However, in renal disease, the ratio between free and total 25VD remained unchained; therefore, total 25VD is the indicator of VD status in CKD [3].
\nGenerally, 25VD level has reverse association with parathyroid hormone (PTH) levels. In addition, higher 25VD is associated with higher calcium intestinal reabsorption. However, at 25VD ≥ 75 nmol/l, no reduction in PTH levels and no increase in calcium intestinal reabsorption occurs [4, 5]. Therefore, 25VD ≥ 75 nmol/l is regarded as a cut-off value for vitamin D sufficiency.
\nNo generally accepted definition for VD deficiency exists, as authors choose cut-off value either serum 25VD of 25 nmol/L [6] or serum 25VD of 50 nmol/L [7]. However, target levels of 75 nmol/L are recommended, taking into consideration the clinical importance of mild VD insufficiency (25VD between 50 and 74.9 nmol/L) [7, 8].
\nChronic kidney disease (CKD) is defined as abnormalities of kidney structure or function, present for more than 3 months, with implications for health [one of the following: estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 m2,presence of proteinuria, structural abnormalities of the kidney detected on imaging, pathological findings detected on kidney biopsy, urine sediment pathology, electrolyte abnormalities due to tubular disorders, history of kidney transplantation] [9]. CKD patients are at increased risk for VD deficiency; therefore, they require VD screening [7].
\nVD is synthesized predominantly endogenously (approx. to 90% of the total VD in human body). In the skin, the ultraviolet light transforms 7-dehydroxycholesterol (provitamin D) to pre-vitamin D, which under the influence of body temperature spontaneously isomerizes to cholecalciferol (vitamin D3). Approximately, 10% of total body VD is taken orally (vitamin D2, ergocalciferol, and cholecalciferol). VD is transported via VD-binding protein to the liver, where it is hydroxylated to 25VD. The next step in VD activation is hydroxylation of 25VD by the enzyme 1α-hydroxylase (CYP27B1) to 1,25VD, which is the active VD metabolite. The process occurs predominantly in the renal tubules. In addition, non-renal CYP27B1 was detected in skin (basal keratinocytes and hair follicles), lymph nodes (granulomata), colon (epithelial cells and parasympathetic ganglia), pancreas (islets), adrenal medulla, brain (cerebellum and cerebral cortex), prostate epithelial cells, and placenta (decidual and trophoblastic cells) [10], indicating the wider significance of the VD metabolites. Finally, 1,25VD is inactivated by the enzyme 24-hydroxylaze.
\n1,25VD exerts its effect via the vitamin D receptor (VDR), which is detected in all human organs. 1,25VD binds to VDR, the complex forms a heterodimer with the receptor for retinoid X (RXR) within the nucleus. The 1,25VD-VDR-RXR complex binds to vitamin D reacting elements, modulating gene expression. The highest expression of VDR is detected in bones, small intestines, and parathyroid gland. VDR activation leads to influencing bone metabolism), increase of calcium and phosphate absorption, and PTH secretion suppression. However, due to the wider VDR distribution in human body, its activation is associated with effects beyond influencing calcium-phosphorus metabolism–renin-angiotensin system (RAS) suppression and cardiac hypertrophy prevention (myocardial VDR), diabetes mellitus control (pancreatic VDR), and immune system modulation (VDR in the immune cells).
\nThe above-mentioned stages of VD metabolism form the so called VD axis.
\nAll levels of VD metabolism are significantly affected in renal disease.
\nCholecalciferol synthesis is reduced in uremic skin. In addition, these patients are usually older, with reduced exposure to sunlight, which is additionally associated with poorer skin VD synthesis. What is more, oral VD intake is decreased due to protein intake reduction.
\n25VD is reduced in CKD due to reduced amount of its precursor, increased loss in nephrotic patients, and 25VD sequestration in adipose tissue due to higher rate of obesity in CKD patients [11, 12].
\nEven during the initial stages of CKD (eGFR below 60 ml/min/1.73 m2) due to reduced phosphate tubular excretion, higher levels of fibroblast growth factor 23 (FGF-23) occur, which suppress CYP27B1 activity. Furthermore, phosphatemia and metabolic acidosis decrease enzyme activity too. In addition, 1,25VD levels in renal disease are reduced because of increased catabolism due to increased FGF-23 levels. Finally, the smaller number of functioning tubules is directly associated with lower 1,25VD production in advanced CKD.
\nVDR is affected in CKD too. Low 1,25VD downregulates of VDR expression [13]. In areas of nodular growth in the parathyroid gland reduced VDR content is detected. In uremia, there is significant decrease in VDR-RXR binding to vitamin D reacting elements, as well as reduced RXR content in the parathyroid glands, explaining increased PTH levels without the presence of hypocalcaemia and hyperphosphatemia [14]. Hypocalcaemia in advanced CKD increases the parathyroid levels of calreticulin, a cytosolic protein that binds the DNA-binding domain of nuclear receptors, thus blocking VDR-mediated transactivation. Higher levels of inflammatory cytokines were found to be associated with impaired binding of VDR-RXR to vitamin D reacting elements, contributing to vitamin D resistance in patients on hemodialysis [15]. Finally, hypocalcaemia in CKD suppresses the calcium-sensing receptor (CaSR) in the parathyroid glands, which in turn downregulates parathyroid VDR expression; use of calcimimetics upregulated VDR expression in rat models [16].
\nThe VD axis in health and renal disease is depicted in Table 1.
\n\n | \n\n | \n\n | \n
---|---|---|
Cholecalciferol/ergocalciferol | \nSkin synthesis from UV light or oral intake | \n\n
| \n
25-hydroxyvitamin D(25VD) | \nHepatic synthesis (25-hydroxylase) | \n\n
| \n
1,25-dihydroxyvitamin D(1,25VD) | \nHydroxylation in renal tubules (1α-hydroxylase) and other organs | \n\n
| \n
Vitamin D receptor(VDR) | \nWidely spread in human body, esp. bone and parathyroid glands (calcium-phosphorus metabolism) In all other organs (pleiotropy) | \n\n
| \n
Vitamin D axis in health and in renal disease.
CKD, chronic kidney disease; VDRE, vitamin D reacting elements; UV, ultraviolet.
The major mechanisms for abnormal VD metabolism and VD deficiency were outlined in the section above. Of particular importance is hyperphosphatemia, caused by initial renal damage, leading to higher FGF-23 levels, which in turn suppresses CYP27B1 activity and increases 1,25VD catabolism. Suboptimal VD levels are the basis of the abnormal calcium-phosphate metabolism in renal disease. Currently, the term CKD-associated mineral bone disorder (CKD-MBD) is used to define the wide spectrum of CKD-related abnormalities in calcium-phosphate metabolism, as their importance spans beyond bone health.
\nCKD-MBD comprises of three major aspects—biochemical abnormalities, bone changes, and vascular calcifications [17].
\nThe biochemical abnormalities in CKD-MBD represent the laboratory aspect of the disorder. These include calcium level (ionized or total), phosphate level, PTH, alkaline phosphatase (total or bone specific), and VD status (25VD). Other indicators, such as 1,25VD and FGF-23 are not measured routinely. The earliest changes occur in PTH and VD metabolites—the abnormal values for PTH, 25VD and 1,25VD are detected in eGFR<60 ml/min/1.73 m2, whereas abnormal calcium and phosphate levels are detected in eGFR below 40 and remain stable until eGFR<20 ml/min/1.73 m2 [18].
\nAccording to the current guidelines, testing for calcium, phosphate, PTH, and alkaline phosphatase should be initiated in eGFR<60 ml/min/1.73 m2; the frequency of laboratory evaluation should be based on the rate of CKD progression, the magnitude of abnormalities, and the evaluation of treatment’s effectivity. Similarly, 25VD should be tested in patients with eGFR<60 ml/min/1.73 m2 and frequency of testing depends on baseline values and therapeutic interventions [17]. The timing and frequency suggested by Kidney Disease: Improving Global Outcomes (KDIGO) are summarized in Table 2.
\n\n | \n\n | \n\n | \n\n | \n
---|---|---|---|
Calcium and phosphorus | \n6–12 months | \n3–6 months | \n1–3 months | \n
PTH and alkaline phosphatase | \nBaseline | \n6–12 months | \n3–6 months | \n
25-Hydroxyvitamin D | \nBaseline | \nBaseline | \nBaseline | \n
Suggested testing for biochemical indicators of CKD-MBD according to CKD stage.
CKD, chronic kidney disease; PTH, parathyroid hormone.
Bone involvement in CKD [renal osteodystrophy (ROD)] is of pivotal importance, as it is associated with bone fractures (asymptomatic or symptomatic), bleeding, chronic disability, poorer life quality, and higher mortality in renal disease. In children with CKD, it leads to growth retardation and skeletal deformities [17].
\nSeveral types of bone histological changes can be detected in CKD, according to three major histological indicators: turnover, mineralization, and volume. Bone turnover (T) is a parameter, corresponding to bone formation rate. It can be abnormally low, normal, or very high and is best assessed via bone biopsy and tetracycline labeling. Mineralization (M) is the second parameter. Normally, the osteoblasts lay down new collagen and direct mineralization of the matrix. This process is impaired in CKD, leading to thickened osteoid. Mineralization is measured by osteoid maturation time and mineralization lag time. The osteoid maturation time is the osteoid width divided by the distance between labels per day. The mineralization lag time is the osteoid maturation time adjusted for the percentage of osteoid surface that has a tetracycline label. Mineralization is classified as normal and abnormal. Bone volume (V) sums up bone formation and resorption rates. It is generally accepted that bone volume is expressed as bone volume per tissue volume and is classified as low, normal, and high bone volume.
\nAccording to the TMV classification of bone histology in CKD, the following ROD categories are recognized [19]:
Adynamic bone disease (AD)—low-turnover bone disease with normal mineralization. Volume can be low, but in some patients with normal mineralization and low turnover, it will be normal. AD is usually associated with PTH over-suppression, including overdose of VD analogs or calcitriol
Mild secondary hyperparathyroidism related bone disease (MHPTBD)—medium-to high bone turnover, any bone volume, normal mineralization
Osteitis fibrosa (OF)—represents a more advanced form of high-turnover disease, compared to MHPT, any bone volume and normal mineralization
Osteomalacia (OM)—low-turnover bone with abnormal mineralization. The bone volume may be low to medium, depending on the severity and duration of the process and other factors that affect bone health
Mixed uremic osteodystrophy (MUO)—represents features of the above mentioned variants; for example, a combination of high-turnover, normal bone volume, with abnormal mineralization
In addition, age related/postmenopausal osteoporosis can be detected. Measurement of bone mineral density [by using dual-energy X-ray absorptiometry (DXA)] is most informative in CKD stages 1–2; in these cases, low BMD is associated with osteoporosis and treatment is performed as in the general population. Patients with low BMD and CKD stages 3–5 are designated as having CKD-MBD with low BMD. Recent reports demonstrate that BMD testing can predict fracture risk in eGFR<60 ml/min/1.73 m2. The current KDIGO guidelines broaden the indications for BMD testing in CKD stages 3–5D to assess fracture risk, if it will have effect on treatment. Finally, normal histology is also possible [17, 20].
\nIt should be noted that histological findings differ according to renal replacement type. In patients on hemodialysis OF and MUO are the most common findings, in peritoneal dialysis–AD is detected in up to 50%, whereas in patients in CKD stages 3–5 not on dialysis the most common findings are OF and MUO. However, in the latter group, the highest percentage of normal histology is detected [20].
\nBone biopsy is regarded as the golden standard for the precise diagnosis of the bone changes in CKD-MBD. Indications for bone biopsy are bone fractures, bone pain, unexplained hypercalcemia/hypophosphatemia, evaluation of the type of bone turnover (which may lead to treatment correction), and suspected aluminum toxicity. Planning antiresorptive treatment in eGFR<30 ml/min/1.73 m2 is currently not an indication for bone biopsy, as no evidence exists, linking bisphosphonate use to higher AD prevalence in CKD [17]. The most widely recognized disadvantages of the procedure are pain, laborious procedure, time-consuming, and expensive histological evaluation, as well as insufficient histopathological expertise [21].
\nThese limitations restrict the wide use of bone biopsy. Therefore, markedly elevated PTH and bone-specific alkaline phosphatase can be used in clinical practice to predict bone turnover in CKD-MBD. Thus, two types of mineral bone diseases are defined—high turnover mineral bone disease (HTMBD) and low turnover mineral bone disease (LTMBD). In cases, in which clinical and laboratory data are inconclusive of the type of bone turnover, bone biopsy should be considered [17]. The clinical, laboratory, radiological, and histological characteristics of the both entities are summarized in Table 3.
\n\n | \n\n | \n\n | \n
---|---|---|
\n | Arthralgia | \nArthralgia | \n
Bone pain | \nBone pain | \n|
Calciphylaxis | \nCalciphylaxis | \n|
Bone fractures | \nBone fractures | \n|
Muscle weakness, spasms, tetany, paresthesia, convulsions (hypocalcaemia) | \nAluminum toxicity—anemia, dementia | \n|
Vomiting, nausea, hypertension (hypercalcemia) | \nVomiting, nausea, hypertension (hypercalcemia) | \n|
Pruritus | \nPruritus | \n|
Myalgia | \n\n | |
\n | \n\n | \n\n | \n
Serum calcium | \nN in early stages ↓/N/↑ in advanced HTMBD | \nEarly stages N/↑ Advanced stages—↑↑ | \n
Serum phosphate | \nN in early stages N to very high in advanced stages | \nEarly stages N/↓ Advanced—↓/↑ | \n
BAP | \nN in early stages ↑ in advanced HTMBD | \nEarly stages N/↓ Advanced—↓ | \n
PTH | \nN/↑ in early stages ↑↑↑ in advanced HTMBD | \nEarly stages N/↓ Advanced stages ↓ | \n
\n | \n\n | \n\n | \n
\n | Subperiosteal erosions—hands, clavicles, and pelvis | \nFractures | \n
Vertebral osteosclerosis | \nLooser zones | \n|
Brown tumors | \nBone deformities | \n|
Extraskeletal calcifications | \nOsteopenia and osteoporosis | \n|
\n | \n\n | \n\n | \n
\n | OF, MHPTBD | \nAD, OM | \n
Clinical presentation, laboratory, radiologic and histologic findings in low turnover mineral bone disease (LTMBD) and high turnover mineral bone disease (HTMBD).
PTH, parathyroid hormone; BAP, bone specific alkaline phosphatase; N, normal; ↓, decreased; ↑, increased values; OF, osteitis fibrosa; MHPTBD, mild secondary hyperparathyroidism related bone disease; AD, adynamic bone disease; OM, osteomalacia.
Vascular calcification (VC) is deposition of calcium phosphate in vascular tissues. It presents with calcification of arterial media, intima, valves, and rarely with calcific uremic arteriolopathy (calciphylaxis). Normally, this occurs with aging. However, the process is accelerated in CKD and leads to increased mortality and morbidity. Initially, it was regarded as a finding in patients with end-stage renal disease (ESRD), but currently, it is detected in early CKD stages in adults and in children with ESRD, thus depicting a more complicated picture [22].
\nPatients with VC are regarded as having the highest risk for cardiovascular events. The diagnosis is based on abdominal lateral radiograph (vascular calcifications), echocardiogram (valvular calcifications), or computer tomography [17].
\nThe association of VC with VD status in CKD is not well defined as contradicting reports exist. Two report demonstrate, that lower serum 1,25VD is associated with increased risk for and demonstrated that 25VD has no association with VC [23, 24]. As arterial stiffening is regarded as related pathology to VC in CKD, it should be noted that two recent interventional studies demonstrated improvement of endothelial dysfunction in CKD patients after cholecalciferol supplementation [25, 26, 27]. Higher serum levels of 1,25VD and high doses of VD supplementation increased the risk for VC [23, 28], thus indicating the dual role of VD in vascular health.
\nFinally, the type of VD treatment may be important too. Generally, vitamin D analogs (VDA) demonstrate similar effectivity in reduction of PTH levels to calcitriol, with lower toxicity—lower rates of hypercalcemia and hyperphosphatemia, thus suggesting lower risk for supplementation-enhanced VC. Unfortunately, more trails are needed to evaluate the effect of different supplementation types on VC prevalence. In addition, new VDA are being evaluated in the treatment of CKD-MBD, with more expressed cardiac protection and less hypercalcemia and hyperphosphatemia than paricalcitol [29, 30, 31].
\nAs mentioned above, the VDR and the enzyme CYP27B1 have wider distribution in the body and are being expressed in organs not involved in calcium-phosphate metabolism. This indicates a greater physiological importance of the VD axis, spanning beyond skeletal physiology. These extraskeletal properties are designated as pleiotropic effects of VD. In this sub-section, the current knowledge of VD pleiotropy in CKD patients will be presented.
\nPoorer VD status was associated with higher proteinuria and faster progression of CKD. In addition, VDR activation was found to slow CKD progression in immune and non-immune renal diseases.
\nIn IgA nephropathy, human studies associated poorer VD status with poorer clinical outcomes [32]. In addition, calcitriol supplementation suppressed proteinuria in IgA patients by activating the VDR and thus influencing cytokine and leukotriene metabolism [33].
\nRecent studies demonstrated the importance of VD axis in systemic lupus erythematosus (SLE) and lupus nephritis (LN). Poorer VD status correlated with higher SLE activity, whereas poorer VDR expression in renal tissue was linked to higher renal activity and more severe renal lesions in patients with LN [34, 35]. Podocyte autophagy is a key factor in renal involvement in LN. A recent study showed that poorer VD status correlated with higher podocyte autophagy activity and VD effectively suppressed it in LN, thus protecting podocytes from antibody-mediated injury [36]. VD and VDR affect autophagy via different mechanisms: activating calcium-dependent intracellular kinases, downregulating mTOR expression, or upregulation of the cyclin-dependent kinase inhibitor p19INK4D [37].
\nHowever, VD has renoprotective effect in non-immune glomerular diseases too. In diabetic nephropathy (DN), both animal models and clinical trials demonstrate the negative correlation between low VD and the risk for DN and DN progression, as well as the beneficial effect of VD/VD analogs in reducing albuminuria, renal fibrosis, thus retarding disease progression [38, 39]. The effect can be explained with RAS suppression, suppression of inflammatory mediators [nuclear factor-kappa B (NF-κB), transforming growth factor-β(TGF-β)], suppressing the Wnt/β-catenin pathway, which is involved in epithelial to mesenchymal cell transition (EMT) in high glucose milieu, as well as upregulation of nephrin expression [39, 40, 41].
\nThe mechanisms mentioned in DN (suppression of RAS, inflammation, EMT) are the basis of renal protection of VD in other renal diseases–in animal models and human clinical trials [33]. Additionally, an inverse correlation between VD status and proteinuria and blood pressure control in autosomal polycystic kidney disease (ADPKD) was reported, as well as reduction of proteinuria and hypertension on treatment with VDR agonist in experimental PKD. However, the findings are to be evaluated prospectively in interventional study in patients with ADPKD [42].
\nThe presence of VDR and CYP27B1 has been well recognized in the immune cells, which modulate their differentiation and proliferation. VD suppresses B-cell proliferation, modulates T-helper proliferation, favoring the T-helper type 2 subtype, thus suppressing inflammatory cytokine synthesis (IL17, IL21) and stimulating the production of anti-inflammatory ones (IL10). In addition, VD enhances the production of cathelicidin and β-defensin 2, as well as influences autophagy and apoptosis [33, 43]. All these properties of VD and VDR demonstrate the importance of VD axis in protective and pathological immunity.
\nThe role of VD in LN has been already discussed. Other studies, evaluating the VD–SLE association demonstrate that poorer VD is related to higher SLE activity in adults and children [44]. Different supplementation regimens also demonstrated improvement in inflammatory markers, disease activity indices, decrease in T-helpers types 1 and 17 [44]. However, despite the different papers, reporting beneficial effect from VD, a recent study demonstrated increase of SLE activity after exposing patients to UV radiation, despite improvement in VD status [45]. Thus, the SLE-VD correlation still remains to be clarified.
\nThe rheumatoid arthritis (RA) and the inflammatory bowel disease (IBD) are diseases that influence kidney health by causing AA amyloidosis, which in turn progresses to ESRD. VD status was inversely associated with RA disease activity and RA-associated complications [46]. However, despite some reports, indicating beneficial effect of VD supplementation on T-helper 17 function, the results for VD supplementation currently are inconsistent [46, 47].
\nSeveral studies demonstrated lower VD status in patients with more aggressive IBD. However, the findings may be attributed to lower absorption of VD due to the active intestinal inflammation, especially in Crohn’s disease [48, 49]. Interventional studies also demonstrated the beneficial effect of VD supplementation in suppressing pro-inflammatory markers in IBD. Yet, the importance of VD in IBD remains to be clarified [50, 51].
\nInfection is a well-recognized leading cause for death in CKD patients, especially those on dialysis. It was already mentioned that the VD axis plays a role in immunity by enhancing cathelicidin production. In dialysis patients, low cathelicidin levels were detected, which were associated with higher risk for infection and also modest correlation to 1,25VD levels was discovered [52]. Interventional studies also demonstrated the decreased risk for infection in dialysis patients. VD supplementation reduced significantly the risk for hospitalization due to acute respiratory infections in hemodialysis (HD) patients; in another study, VD supplementation decreased the risk for peritonitis in patients on peritoneal dialysis (PD) [53, 54]. A more recent study also demonstrated decrease in infection rates in dialysis patients treated with VDR analogs [55]. In contrast to these findings, Yildirim et al. failed to demonstrate a significant relation between VD status and inflammatory markers in CKD patients [56].
\nAn already mentioned paper demonstrated reduced malignancy-associated mortality in VDA-treated dialysis patients. However, the study did not evaluate the specific localization of the neoplasia, nor its histology [55]. Therefore, in this subsection, the most common malignant diseases will be reviewed and their association with VD. Unfortunately, the exact association between VD and neoplasia in CKD patients is not well evaluated, as CKD patients are usually excluded from large trials and registries [57].
\nThe reports evaluating the association between VD deficiency and breast cancer are inconsistent. The inverse association between breast cancer and VD, detected in several studies was not supported by more recent prospective studies. In addition, a controversy exists about the beneficial effect of VD supplementation on breast cancer risk and survival [44]. Unfortunately, the cited studies did not demonstrate data for CKD patients.
\nSeveral studies demonstrate an inverse correlation between colorectal cancer and 25VD levels [58, 59]. The findings do not correspond to the results of a larger study, detecting no significant association between colorectal cancer and VD status [60]. Unfortunately, the data from interventional trails with VD supplementation also have conflicting result for the effect of VD on colorectal cancer prevention and survival improvement [44, 61]. Similarly to breast cancer, the data for the association between colorectal cancer and VD status in renal patients is limited.
\nThe results about the influence of VD on the risk for other malignancies are controversial. A large study (n = 70,563) evaluated the association of 25VD levels on the risk for prostate cancer, breast cancer, lung cancer, pancreatic cancer, colorectal cancer, ovarian cancer, and neuroblastoma. 25VD concentrations did not correspond to the risk for any of the mentioned neoplasias. Therefore, the authors do not support the regular VD screening as an attempt for cancer prevention [62]. In addition, a large multicenter study in patients on hemodialysis also did not demonstrate significant association between total cancer prevalence and VD deficiency [63].
\nMultiple myeloma (MM) is a plasma cell disease that often presents with kidney manifestations. Several studies reported high rates of VD deficiency in MM patients and specific alleles for VDR were associated with higher risk for MM [64, 65]. Lauter and Schmidt-Wolf established that lower VD levels were associated with more expressed plasma cell infiltration of the bone marrow. In this study, VD supplementation improved anemia, led to higher white blood cell and lower platelet count [66]. Yet, the risk for hypercalcemia should be taken into consideration when VD supplementation is applied in MM patients.
\nBasic science studies demonstrated improvement in glucose metabolism due to immunomodulatory effect (especially in diabetes type 1), improvement of β cell function by increase in insulin secretion, and decreasing insulin resistance by stimulating insulin receptor expression via activating the VDR. Other mechanisms such as RAS suppression and anti-inflammatory effect of VD were also taken into consideration. However, observational studies do not establish clear relationship between VD status and DM prevalence, as some studies support the association, whereas others do not [44]. Interventional trials also have conflicting results. Two recent prospective studies showed improvement in glucose metabolism after vitamin D supplementation was applied [67, 68]. Unfortunately, the studies did not evaluate patients with renal disease. Two interventional studies with paricalcitol failed to detect improvement in insulin resistance in patients CKD stages 3 and 4 and in dialysis [69, 70].
\nCVD is a leading cause for mortality in CKD. As VDR and 27CYPB1 are expressed in the cells of the cardiovascular system, it could be expected that the VD axis can play a beneficial role in cardio-vascular health. A possible cardioprotection can be explained with RAS suppression and anti-inflammatory effects; VDR activation can improve cardiac muscle cells contractility and modulate their proliferation and growth. In addition, VD can improve peripheral vascular health by affecting endothelial and smooth muscular cells too [71].
\nEven though the association between VD deficiency and CVD has been recognized in the general population and in CKD, large randomized interventional studies failed to demonstrate improvement from VD supplementation in cardiovascular outcomes, cardiac structure, or function in CKD patients [72]. An improvement in blood pressure control and endothelial function (as measured by brachial artery flow-mediated dilatation) was observed after VD supplementation in the general population; however, in CKD patients, no significant antihypertensive effect was detected [73]. Similarly, the results for the effect on VD supplementation on arterial stiffness and endothelial function are conflicting [72, 73]. Therefore, the use of VD in renal disease in order to improve cardiovascular events is currently not recommended [72].
\nIn hemodialysis (HD) patients, a positive relationship between muscle strength and VD levels was detected, with optimal handgrip strength in 25VD above 30 ng/ml (75 nmol/L). In ESRD patients, suboptimal VD was associated with lower quadriceps mass and increased risk for falls [74]. In addition, in PD patients, low 25VD was found to be the independent factor for global cognitive impairment due to the antioxidant and neuroprotective role of 1,25VD. This is of crucial importance, as PD is a home-based renal replacement therapy that needs adequate cognition and self-monitoring [75].
\nTreatment with VDA led to the improvement of anemia in ESRD patients. A possible mechanism is suppression of inflammation and direct stimulation of erythropoiesis. In addition, paricalcitol reduced PD-associated thickening of the peritoneum and prevented peritoneal fibrosis in animal models. However, recent study in PD patients did not detect any benefit from paricalcitol supplementation in preventing peritoneal remodeling. In contrast to these results, Kerschbaum et al. demonstrated protective effect of oral active VD against peritonitis in PD patients [33, 54, 76].
\nSuboptimal 25VD is a commonly detected problem after kidney transplantation (KT) with prevalence above 80% of the kidney transplant recipients (KTRs). As KTRs are CKD patients, all mentioned factors, predisposing to impaired VD metabolism are valid for this cohort of patients, especially considering the fact that more than 50% of the KTRs have GFR<60 ml/min/1.73 m2. In addition, transplant-specific factors influence VD synthesis: sun exposure avoidance due to the increased risk for skin malignancies, use of sun-protecting cosmetics (limiting further UV exposure), proteinuria after KT (increased loss in urine), higher prevalence of obesity after KT (reduced bioavailability), the presence of new onset diabetes after transplantation (NODAT) (by reducing intestinal absorption), use of steroids (increased 1,25VD catabolism), and calcineurin inhibitors (impaired 25VD liver synthesis) [77, 78]. Similarly to CKD in native kidneys, the VD-associated clinical implications after KT are categorized as post-transplant mineral bone disorder (PTMBD) and VD pleiotropy.
\nSimilarly to native kidneys, PTMBD consists of three aspects—biochemical abnormalities, bone involvement, vascular pathology and is associated with higher risk for fractures and death.
\nSignificant changes occur in the biochemical indicators of calcium-phosphorus metabolism after KT. In the early post-transplant period, the fluctuations in the parameters are more pronounced as the graft function is rapidly changing. Due to the presence of functioning renal tubules and still high levels of PTH and FGF-23, hypophosphatemia and mild hypercalcemia are common. These changes usually normalize within months after KT as graft function stabilizes. Therefore, the current KDIGO guidelines recommend at least weekly testing for calcium and phosphorus immediately after KT [17]. FGF-23 and PTH rapidly decrease; however, PTH may be significantly elevated years after successful KT due to parathyroid cell hypertrophy. VD levels are low in the early post-transplant period; yet, suboptimal levels are very common later after KT [78].
\nIn the late post-transplant period, current guidelines recommend the testing for calcium, phosphorus, PTH, and alkaline phosphatase to be performed according to the magnitude of the abnormalities, rate of progression of post-transplant CKD, and the presence of medical treatment. Practically, the timing is similar to patients with CKD stage 3–5 with native kidneys (see Table 2). 25VD should be tested at baseline and repeated testing should be performed according to the initial level and the presence of medical interventions. In our center, 25VD levels are monitored twice annually, taking into consideration its seasonal variations in the general population. Thus, a significant deterioration of VD status in the winter/fall was detected, allowing adequate seasonal supplementation to be initiated.
\nPost-transplant bone disease is commonly observed after KT and encompasses ROD, osteoporosis, bone fractures, and osteonecrosis. Deterioration in BMD occurs mainly during the first 12 months, though BMD loss persists at lower rates after the first post-transplant year. The etiology is multifactorial: pre-existing CKD-MBD, duration of dialysis and transplantation, poor graft function, hypogonadism, higher rates of diabetes after KT, suboptimal VD levels, and use of immunosuppressive agents. Of these, steroids are of particular importance as their cumulative and mean dose is associated with decreased bone formation and bone density. Some reports indicate that calcineurin inhibitors can rise PTH levels and increase the risk of osteoporosis, but the findings are not uniformly accepted [17, 79].
\nIn KTRs, not only fracture prevalence is significantly increased compared to the general population, but also fracture-associated complications, including mortality, are more common in the post-transplant setting. Major fracture sites are the hip (usually osteoporosis-associated) and the ankle/foot (atypical for osteoporosis), which demonstrate that both ROD and osteoporosis play an important role in bone fragility [80].
\nThe use of DXA–BMD measurement is getting more attention in native CKD, as a growing body of evidence demonstrates that it can predict fracture risk across CKD categories. To date, only one retrospective study, total hip DXA measurement after KT was associated with increased fracture risk. In addition, a recent prospective study had similar findings [81, 82]. Despite the insufficient evidence for KTRs, KDIGO suggests the use of BMD testing in all stages of post-transplant CKD in KTRs with high risk for osteoporosis, if the measurement will have effect on treatment. Bone biopsy can be considered to guide treatment [17].
\nVC is common after KT and is usually associated with pre-transplant uremia. In addition, most studies are semi-quantitative, thus making post-transplant VC progression assessment difficult. However, there are studies demonstrating a stop in progression or even improvement in VC in KTRs [83, 84]. Recognized risk factors for VC after KT are statin use, low 25VD levels, male sex, older age, and higher phosphate levels [85]. The data for the effect of immunosuppressive agents are conflicting. Mycophenolates proved to have protective effects against calcification, especially compared to steroids and calcineurin inhibitors; rapamycin suppressed smooth muscle cell proliferation, whereas everolimus impaired the vasoactive and antithrombotic function of the endothelium [86]. Therefore, more studies are needed in order to evaluate the effect of KT on VC.
\nThe graft survival at the tenth year after KT is significantly lower than the survival during the first 12 months. The explanation for these unsatisfactory results is poorer patient survival due to neoplasia, CVD, NODAT, calcineurin toxicity. It could be hypothesized that VD can improve graft and patient survival due to its pleiotropy. However, the trials in KTRs are small in number and in size, thus further research in this sphere is warranted.
\nObservational studies linked poor VD status to poorer graft outcomes [86]. Our results also demonstrated that higher VD is associated with lower post-transplant proteinuria [87]. However, interventional studies did not fully support the VD–graft function association. Cholecalciferol supplementation failed to demonstrate renoprotection in prospective study [88]. However, in a recent prospective placebo-controlled study, paricalcitol ameliorated proteinuria in KTRs [89].
\nObservational studies demonstrated higher rates of acute rejection in VD deficient KTRs [90]. Unfortunately, interventional studies did not find protective role of cholecalciferol supplementation on rejection prevalence [88]. Therefore, the role of VD in rejection prevention after KT is not fully understood and is under debate.
\nInfection is a major cause for death after KT. Several recent reports established negative correlation between VD status and infection risk, especially for cytomegalovirus and BK virus infections in KTRs [91, 92]. However, our observational study showed no association between VD status and prevalence of urinary tract infections after KT [93]. Furthermore, the VITA-D study did not establish positive effect of cholecalciferol supplementation on infection risk [88]. A probable explanation for the discrepancies in the studies are the different types of infection evaluated (e.g. in the VITA-D study the total infection risk was assessed). Probably, a more specific approach should be chosen and the infection risk for specific etiological agent and its association to VD should be analyzed.
\nDespite the anti-neoplastic properties of VD in vitro and in animal models, the evidence for anti-malignancy effect of VD in CKD patients and KTRs is insufficient. Observational studies report conflicting results for the association between post-transplant malignancies and VD status [86]. A recent study in our transplant center showed that VD-deficient KTRs had higher prevalence of non-cutaneous cancers [94]. A single center study established beneficial effect from active VD supplementation on post-transplant neoplasia rates [95]. The larger prospective, multicenter, double-blind, randomized, controlled study VITALE is currently being performed, which will evaluate the effect of cholecalciferol supplementation on malignancy risk after KT [96].
\nThe major risk factors for NODAT are use of steroids and calcineurin inhibitors. The data for VD-NODAT association are insufficient. The trial VITALE is to assess the effect of high and low doses cholecalciferol in VD–insufficient KTRs on NODAT prevalence [96].
\nMarchal et al. established a significant association between lower 25VD and vascular calcification after KT [85]. However, a more recent study did not find a relationship between VD status and post-transplant hypertension and major CV events [97]. One of the aims of the already mentioned trial VITALE is to assess the effect of cholecalciferol supplementation on blood pressure control and CVD rates in KTRs [96].
\nSupplementation with cholecalciferol (vitamin D3), ergocalciferol (vitamin D2), or treatment with the active vitamin D calcitriol or VDA suppresses PTH in secondary hyperparathyroidism in CKD. As a first step, a correction of hypocalcemia, hyperphosphatemia, and suboptimal 25VD levels should be performed. In more advanced CKD-related secondary hyperparathyroidism calcitriol and VDA can be initiated. It should be noted that over-suppression of the parathyroid gland due to overdose of the VD treatment is a major cause for AD. Therefore PTH, as well as serum phosphate and calcium, should be regularly monitored. It should be noted that the optimal PTH values for dialysis patients are two times up to nine times the upper normal limit, whereas for patients not on dialysis the optimal range is not established. If trend for lowering/rising values is present, changes in treatment should be changed so that the negative trends be reverted [17]. Similarly, in KTRs cholecalciferol/calcitriol/VDA treatment should also take these trends into consideration.
\nIn the general adult population, supplementation doses of VD at least 600 IU daily; however, if improvement in VD status is needed, doses of at least 1500–2000 IU per day should be prescribed. The maximal dose VD without medical supervision should be 4000 IU daily. Cholecalciferol and ergocalciferol are equally effective [98]. The KDIGO guidelines recommend VD deficiency in CKD patients and in KTRs to be treated as in the general population. It is the initial therapeutic step, together with correction of hypocalcemia and hyperphosphatemia, as it effectively suppresses PTH in CKD stages 3–5 not on dialysis. More aggressive approach is to be avoided as modest PTH elevation is regarded as adaptive mechanism in declining GFR [17].
\nCalcitriol is naturally existing 1,25VD, whereas VDA are synthetic derivatives of vitamin D2 (paricalcitol, doxercalciferol) and vitamin D3 (alfacalcidol, falecalcitriol, 22-oxacalcitriol). Despite the existing trials demonstrating positive effect of calcitriol/VDA on biochemical abnormalities, more recent studies do not demonstrate improvement in patient-centered end-points, such as left ventricular mass index and heart function; however, hypercalcemia was observed. Taking into account that modest PTH elevation is a possible adaptive response in CKD, the lack of significant clinical effects and higher risk for hypercalcemia, the use of calcitriol and VDA is not routinely recommended in CKD stages 3–5 not on dialysis. Their use is advocated in cases of severe and progressive secondary hyperparathyroidism and eGFR below 30 ml/min/1.73 m2 or dialysis patients [17].
\nThe data for hypercalcemia rates in calcitriol and VDA are conflicting. Zand et al. demonstrated lower hypercalcemia prevalence in patients treated with paricalcitol; other reports established no difference in hypercalcemia between calcitriol and paricalcitol [29, 99].
\nOther measures, recommended by KDIGO that optimize VD treatment in CKD-MBD are avoidance of hypercalcemia, reduction of phosphate serum levels, including phosphate dietary restriction, limitation of the use of calcium-based phosphate binders, calcium dialysate concentrations within the range of 1.25 and 1.50 mmol/l [17].
\nCalcifediol is an oral 25-hydroxyvitamin D3. A study demonstrated reduction in PTH levels without changes in phosphate, calcium, and FGF-23 levels in CKD patients. In this chapter, patient-related outcomes were not assessed [100]. Further trials are needed to clarify the use of calcifediol in renal disease.
\nVitamin K plays a crucial role in vascular health. It serves as a cofactor for γ-glutamyl carboxylation, which converts glutamate into γ-carboxyglutamate (Gla). In vitamin K insufficiency, which is common in CKD, higher levels of desphosphorylated-uncarboxylated matrix Gla-protein (MGP) are established, which are associated with VC, as MGP serves as calcification inhibitor. Vitamin K supplementation increases MGP carboxylation. What is more, VD supplementation upregulates MGP synthesis, whereas vitamin K suppressed 1,25VD-associated calcinosis [101, 102]. Therefore, it can be hypothesized that vitamin K supplementation in CKD can be an adjuvant treatment to VD supplementation and will decrease its adverse effects. Further research of the efficacy and safety of vitamin K supplementation in CKD is needed.
\nVD deficiency in renal patients has been a burning issue in nephrology for many years. Yet, many questions remain unanswered. Of particular interest are the effect on VD treatment on clinical outcomes, especially death and cardiovascular events; VD-associated adverse events in CKD; VD pleiotropy in renal disease (randomized controlled prospective interventional studies are needed); the use of novel therapeutic agents should be further evaluated (vitamin K, new VDA, calcifediol). In addition, new biomarkers, evaluating bone health in CKD and new techniques, evaluating BMD and fracture risk may guide VD treatment more accurately. Therefore, new diagnostic and therapeutic strategies can be expected in the future.
\nThe authors declare no conflict of interest.
IntechOpen Compacts provide a mid-length publishing format which bridges the gap between journal articles, book chapters and monographs, and cover content across all scientific disciplines. Compacts are the preferred publishing option for brief research reports on new topics, in-depth case studies, dissertations, or essays exploring new ideas, issues or broader topics on the research subject.
",metaTitle:"IntechOpen Compacts",metaDescription:"IntechOpen Compacts present a mid-length publishing format which bridges the gap between journal articles, book chapters, and monographs and covers content across all scientific disciplines.",metaKeywords:null,canonicalURL:"/page/compacts",contentRaw:'[{"type":"htmlEditorComponent","content":"Without sacrificing the quality of carefully edited and produced peer-reviewed content, Compacts are published as part of IntechOpen’s book collection but on a faster schedule, typically 4-6 weeks after acceptance. With an average of 132,000 visitors per week, publishing in Compacts not only guarantees high visibility but also facilitates international content sharing. As a fully Open Access publisher, the utilization of a CC BY NC 4.0 license means that other researchers will never have to pay permission fees and can adapt, use, and further build upon the material published in Compacts, eliminating any barriers to the further development of scientific research.
\\n\\nCOMPACTS-SHORT FORM MONOGRAPH
\\n\\nCOST
\\n\\n4,000 GBP Compacts Monograph - Short Form
\\n\\nThe final price will depend on the volume of the publication and includes project management, editorial and peer-review services, technical editing, language copyediting, cover design, book layout, book promotion and ISBN assignment.
\\n\\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate applicable in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\\n\\nOptional Services
\\n\\nIntechOpen has collaborated with Enago, through its sister company, Ulatus – one of the world’s leading providers of book translation services. The services are designed to convey the essence of your work seamlessly to readers from across the globe in their own language. Enago’s expert translators incorporate cultural nuances in translations to make the content relevant for local audiences while retaining the original meaning and style. With a high degree of linguistic and subject expertise, Enago translators are equipped to handle all complex and multiple overlapping themes encompassed in a single book to deliver a superior quality of translation.
\\n\\nIntechOpen Authors that wish to use this service will receive a 20% discount on all translation work. For more information or a quote, please visit: https://www.enago.com/intech.
\\n\\nFUNDING
\\n\\nWe feel that financial barriers should never prevent researchers from publishing their research. Please consult our Open Access Funding page to explore funding opportunities and learn more about how you can finance your IntechOpen publication.
\\n\\nBENEFITS
\\n\\nPUBLISHING PROCESS STEPS
\\n\\nSee a complete overview and description of the steps involved in the publishing process here.
\\n\\nSEND YOUR PROPOSAL
\\n\\nIf you are interested in publishing your book with IntechOpen, please submit your book proposal by completing the Publishing Proposal Form.
\\n\\nNot sure if this is the right option for you? Please refer back to the main Publish with IntechOpen page or feel free to contact us directly at book.department@intechopen.com
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Without sacrificing the quality of carefully edited and produced peer-reviewed content, Compacts are published as part of IntechOpen’s book collection but on a faster schedule, typically 4-6 weeks after acceptance. With an average of 132,000 visitors per week, publishing in Compacts not only guarantees high visibility but also facilitates international content sharing. As a fully Open Access publisher, the utilization of a CC BY NC 4.0 license means that other researchers will never have to pay permission fees and can adapt, use, and further build upon the material published in Compacts, eliminating any barriers to the further development of scientific research.
\n\nCOMPACTS-SHORT FORM MONOGRAPH
\n\nCOST
\n\n4,000 GBP Compacts Monograph - Short Form
\n\nThe final price will depend on the volume of the publication and includes project management, editorial and peer-review services, technical editing, language copyediting, cover design, book layout, book promotion and ISBN assignment.
\n\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate applicable in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\n\nOptional Services
\n\nIntechOpen has collaborated with Enago, through its sister company, Ulatus – one of the world’s leading providers of book translation services. The services are designed to convey the essence of your work seamlessly to readers from across the globe in their own language. Enago’s expert translators incorporate cultural nuances in translations to make the content relevant for local audiences while retaining the original meaning and style. With a high degree of linguistic and subject expertise, Enago translators are equipped to handle all complex and multiple overlapping themes encompassed in a single book to deliver a superior quality of translation.
\n\nIntechOpen Authors that wish to use this service will receive a 20% discount on all translation work. For more information or a quote, please visit: https://www.enago.com/intech.
\n\nFUNDING
\n\nWe feel that financial barriers should never prevent researchers from publishing their research. Please consult our Open Access Funding page to explore funding opportunities and learn more about how you can finance your IntechOpen publication.
\n\nBENEFITS
\n\nPUBLISHING PROCESS STEPS
\n\nSee a complete overview and description of the steps involved in the publishing process here.
\n\nSEND YOUR PROPOSAL
\n\nIf you are interested in publishing your book with IntechOpen, please submit your book proposal by completing the Publishing Proposal Form.
\n\nNot sure if this is the right option for you? Please refer back to the main Publish with IntechOpen page or feel free to contact us directly at book.department@intechopen.com
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5684},{group:"region",caption:"Middle and South America",value:2,count:5166},{group:"region",caption:"Africa",value:3,count:1682},{group:"region",caption:"Asia",value:4,count:10211},{group:"region",caption:"Australia and Oceania",value:5,count:887},{group:"region",caption:"Europe",value:6,count:15616}],offset:12,limit:12,total:117315},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"title"},books:[{type:"book",id:"9801",title:"A Comprehensive Review of Compartment Syndrome",subtitle:null,isOpenForSubmission:!0,hash:"ba676e67fb29de60aee9048ff13bf479",slug:null,bookSignature:"Dr. Saqeb Mirza and Dr. Khaled Elawady",coverURL:"https://cdn.intechopen.com/books/images_new/9801.jpg",editedByType:null,editors:[{id:"99767",title:"Dr.",name:"Saqeb",surname:"Mirza",slug:"saqeb-mirza",fullName:"Saqeb Mirza"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10352",title:"Abdominal Surgery",subtitle:null,isOpenForSubmission:!0,hash:"0d1d92b2286b03cf2fd8d88368d9d9cb",slug:null,bookSignature:"Dr. Ahmad Zaghal and Dr. arwa El Rifai",coverURL:"https://cdn.intechopen.com/books/images_new/10352.jpg",editedByType:null,editors:[{id:"240621",title:"Dr.",name:"Ahmad",surname:"Zaghal",slug:"ahmad-zaghal",fullName:"Ahmad Zaghal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9767",title:"Acidophiles - Fundamentals and Applications",subtitle:null,isOpenForSubmission:!0,hash:"083648f001eb64682f9ddb527f0e849e",slug:null,bookSignature:"Dr. Jianqiang Lin, Dr. Jianqun Lin and Dr. Lin-xu Chen",coverURL:"https://cdn.intechopen.com/books/images_new/9767.jpg",editedByType:null,editors:[{id:"16859",title:"Dr.",name:"Jianqiang",surname:"Lin",slug:"jianqiang-lin",fullName:"Jianqiang Lin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10893",title:"Actinobacteria",subtitle:null,isOpenForSubmission:!0,hash:"f27d8e2719160021d634fbf39a4ae913",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10893.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10376",title:"Adaptive Filtering - Recent Advances and Practical Implementation",subtitle:null,isOpenForSubmission:!0,hash:"143698bdab370da4f6c14ddf8624488c",slug:null,bookSignature:"Prof. Wenping Cao and Dr. Qian Zhang",coverURL:"https://cdn.intechopen.com/books/images_new/10376.jpg",editedByType:null,editors:[{id:"174154",title:"Prof.",name:"Wenping",surname:"Cao",slug:"wenping-cao",fullName:"Wenping Cao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10572",title:"Advancements in Chromophore and Bio-Chromophore Research",subtitle:null,isOpenForSubmission:!0,hash:"4aca0af0356d8d31fa8621859a68db8f",slug:null,bookSignature:"Dr. Rampal Pandey",coverURL:"https://cdn.intechopen.com/books/images_new/10572.jpg",editedByType:null,editors:[{id:"338234",title:"Dr.",name:"Rampal",surname:"Pandey",slug:"rampal-pandey",fullName:"Rampal Pandey"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10471",title:"Advances in Dynamical Systems Theory, Models, Algorithms and Applications",subtitle:null,isOpenForSubmission:!0,hash:"689fdf3cdc78ade03f0c43a245dcf818",slug:null,bookSignature:"Dr. Bruno Carpentieri",coverURL:"https://cdn.intechopen.com/books/images_new/10471.jpg",editedByType:null,editors:[{id:"92921",title:"Dr.",name:"Bruno",surname:"Carpentieri",slug:"bruno-carpentieri",fullName:"Bruno Carpentieri"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10370",title:"Advances in Fundamental and Applied Research on Spatial Audio",subtitle:null,isOpenForSubmission:!0,hash:"f16232a481c08a05cc191ac64cf2c69e",slug:null,bookSignature:"Dr. Brian FG Katz and Dr. Piotr Majdak",coverURL:"https://cdn.intechopen.com/books/images_new/10370.jpg",editedByType:null,editors:[{id:"278731",title:"Dr.",name:"Brian FG",surname:"Katz",slug:"brian-fg-katz",fullName:"Brian FG Katz"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7901",title:"Advances in Germ Cell Biology – New Technologies, Applications and Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"4adab31469b82dd5a99eec04dbbe09f2",slug:null,bookSignature:"Ph.D. Sonia Oliveira and Prof. Maria De Lourdes Pereira",coverURL:"https://cdn.intechopen.com/books/images_new/7901.jpg",editedByType:null,editors:[{id:"323848",title:"Ph.D.",name:"Sonia",surname:"Oliveira",slug:"sonia-oliveira",fullName:"Sonia Oliveira"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10629",title:"Advances in High-Entropy Alloys - Materials Research, Exotic Properties and Applications",subtitle:null,isOpenForSubmission:!0,hash:"eef8e329dc2559a9dbe5f1522ec690e3",slug:null,bookSignature:"Prof. Jiro Kitagawa",coverURL:"https://cdn.intechopen.com/books/images_new/10629.jpg",editedByType:null,editors:[{id:"210570",title:"Prof.",name:"Jiro",surname:"Kitagawa",slug:"jiro-kitagawa",fullName:"Jiro Kitagawa"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10374",title:"Advances in Micro- and Nanofluidics",subtitle:null,isOpenForSubmission:!0,hash:"b7ba9cab862a9bca2fc9f9ee72ba5eec",slug:null,bookSignature:"Prof. S. M. Sohel Murshed",coverURL:"https://cdn.intechopen.com/books/images_new/10374.jpg",editedByType:null,editors:[{id:"24904",title:"Prof.",name:"S. M. Sohel",surname:"Murshed",slug:"s.-m.-sohel-murshed",fullName:"S. M. Sohel Murshed"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10531",title:"Advances in Nanoparticle Research for Biomedical Applications",subtitle:null,isOpenForSubmission:!0,hash:"1e9e08e7275f2b928af7911b523252f1",slug:null,bookSignature:"Dr. Maria Carmo Pereira, MSc. Maria João Ramalho and Dr. Joana A. Loureiro",coverURL:"https://cdn.intechopen.com/books/images_new/10531.jpg",editedByType:null,editors:[{id:"82791",title:"Dr.",name:"Maria Carmo",surname:"Pereira",slug:"maria-carmo-pereira",fullName:"Maria Carmo Pereira"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:9},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:18},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:7},{group:"topic",caption:"Computer and Information Science",value:9,count:10},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:5},{group:"topic",caption:"Engineering",value:11,count:15},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:5},{group:"topic",caption:"Materials Science",value:14,count:4},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:60},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:1},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:3},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:307},popularBooks:{featuredBooks:[{type:"book",id:"7802",title:"Modern Slavery and Human Trafficking",subtitle:null,isOpenForSubmission:!1,hash:"587a0b7fb765f31cc98de33c6c07c2e0",slug:"modern-slavery-and-human-trafficking",bookSignature:"Jane Reeves",coverURL:"https://cdn.intechopen.com/books/images_new/7802.jpg",editors:[{id:"211328",title:"Prof.",name:"Jane",middleName:null,surname:"Reeves",slug:"jane-reeves",fullName:"Jane Reeves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,isOpenForSubmission:!1,hash:"13aaddf5fdbbc78387e77a7da2388bf6",slug:"animal-reproduction-in-veterinary-medicine",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9961",title:"Data Mining",subtitle:"Methods, Applications and Systems",isOpenForSubmission:!1,hash:"ed79fb6364f2caf464079f94a0387146",slug:"data-mining-methods-applications-and-systems",bookSignature:"Derya Birant",coverURL:"https://cdn.intechopen.com/books/images_new/9961.jpg",editors:[{id:"15609",title:"Dr.",name:"Derya",middleName:null,surname:"Birant",slug:"derya-birant",fullName:"Derya Birant"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9157",title:"Neurodegenerative Diseases",subtitle:"Molecular Mechanisms and Current Therapeutic Approaches",isOpenForSubmission:!1,hash:"bc8be577966ef88735677d7e1e92ed28",slug:"neurodegenerative-diseases-molecular-mechanisms-and-current-therapeutic-approaches",bookSignature:"Nagehan Ersoy Tunalı",coverURL:"https://cdn.intechopen.com/books/images_new/9157.jpg",editors:[{id:"82778",title:"Ph.D.",name:"Nagehan",middleName:null,surname:"Ersoy Tunalı",slug:"nagehan-ersoy-tunali",fullName:"Nagehan Ersoy Tunalı"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8686",title:"Direct Torque Control Strategies of Electrical Machines",subtitle:null,isOpenForSubmission:!1,hash:"b6ad22b14db2b8450228545d3d4f6b1a",slug:"direct-torque-control-strategies-of-electrical-machines",bookSignature:"Fatma Ben Salem",coverURL:"https://cdn.intechopen.com/books/images_new/8686.jpg",editors:[{id:"295623",title:"Associate Prof.",name:"Fatma",middleName:null,surname:"Ben Salem",slug:"fatma-ben-salem",fullName:"Fatma Ben Salem"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7434",title:"Molecular Biotechnology",subtitle:null,isOpenForSubmission:!1,hash:"eceede809920e1ec7ecadd4691ede2ec",slug:"molecular-biotechnology",bookSignature:"Sergey Sedykh",coverURL:"https://cdn.intechopen.com/books/images_new/7434.jpg",editors:[{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",slug:"sergey-sedykh",fullName:"Sergey Sedykh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9839",title:"Outdoor Recreation",subtitle:"Physiological and Psychological Effects on Health",isOpenForSubmission:!1,hash:"5f5a0d64267e32567daffa5b0c6a6972",slug:"outdoor-recreation-physiological-and-psychological-effects-on-health",bookSignature:"Hilde G. Nielsen",coverURL:"https://cdn.intechopen.com/books/images_new/9839.jpg",editors:[{id:"158692",title:"Ph.D.",name:"Hilde G.",middleName:null,surname:"Nielsen",slug:"hilde-g.-nielsen",fullName:"Hilde G. Nielsen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9208",title:"Welding",subtitle:"Modern Topics",isOpenForSubmission:!1,hash:"7d6be076ccf3a3f8bd2ca52d86d4506b",slug:"welding-modern-topics",bookSignature:"Sadek Crisóstomo Absi Alfaro, Wojciech Borek and Błażej Tomiczek",coverURL:"https://cdn.intechopen.com/books/images_new/9208.jpg",editors:[{id:"65292",title:"Prof.",name:"Sadek Crisostomo Absi",middleName:"C. Absi",surname:"Alfaro",slug:"sadek-crisostomo-absi-alfaro",fullName:"Sadek Crisostomo Absi Alfaro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9139",title:"Topics in Primary Care Medicine",subtitle:null,isOpenForSubmission:!1,hash:"ea774a4d4c1179da92a782e0ae9cde92",slug:"topics-in-primary-care-medicine",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/9139.jpg",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9343",title:"Trace Metals in the Environment",subtitle:"New Approaches and Recent Advances",isOpenForSubmission:!1,hash:"ae07e345bc2ce1ebbda9f70c5cd12141",slug:"trace-metals-in-the-environment-new-approaches-and-recent-advances",bookSignature:"Mario Alfonso Murillo-Tovar, Hugo Saldarriaga-Noreña and Agnieszka Saeid",coverURL:"https://cdn.intechopen.com/books/images_new/9343.jpg",editors:[{id:"255959",title:"Dr.",name:"Mario Alfonso",middleName:null,surname:"Murillo-Tovar",slug:"mario-alfonso-murillo-tovar",fullName:"Mario Alfonso Murillo-Tovar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8697",title:"Virtual Reality and Its Application in Education",subtitle:null,isOpenForSubmission:!1,hash:"ee01b5e387ba0062c6b0d1e9227bda05",slug:"virtual-reality-and-its-application-in-education",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/8697.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7831",title:"Sustainability in Urban Planning and Design",subtitle:null,isOpenForSubmission:!1,hash:"c924420492c8c2c9751e178d025f4066",slug:"sustainability-in-urban-planning-and-design",bookSignature:"Amjad Almusaed, Asaad Almssad and Linh Truong - Hong",coverURL:"https://cdn.intechopen.com/books/images_new/7831.jpg",editors:[{id:"110471",title:"Dr.",name:"Amjad",middleName:"Zaki",surname:"Almusaed",slug:"amjad-almusaed",fullName:"Amjad Almusaed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5138},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9208",title:"Welding",subtitle:"Modern Topics",isOpenForSubmission:!1,hash:"7d6be076ccf3a3f8bd2ca52d86d4506b",slug:"welding-modern-topics",bookSignature:"Sadek Crisóstomo Absi Alfaro, Wojciech Borek and Błażej Tomiczek",coverURL:"https://cdn.intechopen.com/books/images_new/9208.jpg",editors:[{id:"65292",title:"Prof.",name:"Sadek Crisostomo Absi",middleName:"C. Absi",surname:"Alfaro",slug:"sadek-crisostomo-absi-alfaro",fullName:"Sadek Crisostomo Absi Alfaro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9139",title:"Topics in Primary Care Medicine",subtitle:null,isOpenForSubmission:!1,hash:"ea774a4d4c1179da92a782e0ae9cde92",slug:"topics-in-primary-care-medicine",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/9139.jpg",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8697",title:"Virtual Reality and Its Application in Education",subtitle:null,isOpenForSubmission:!1,hash:"ee01b5e387ba0062c6b0d1e9227bda05",slug:"virtual-reality-and-its-application-in-education",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/8697.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9343",title:"Trace Metals in the Environment",subtitle:"New Approaches and Recent Advances",isOpenForSubmission:!1,hash:"ae07e345bc2ce1ebbda9f70c5cd12141",slug:"trace-metals-in-the-environment-new-approaches-and-recent-advances",bookSignature:"Mario Alfonso Murillo-Tovar, Hugo Saldarriaga-Noreña and Agnieszka Saeid",coverURL:"https://cdn.intechopen.com/books/images_new/9343.jpg",editors:[{id:"255959",title:"Dr.",name:"Mario Alfonso",middleName:null,surname:"Murillo-Tovar",slug:"mario-alfonso-murillo-tovar",fullName:"Mario Alfonso Murillo-Tovar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9785",title:"Endometriosis",subtitle:null,isOpenForSubmission:!1,hash:"f457ca61f29cf7e8bc191732c50bb0ce",slug:"endometriosis",bookSignature:"Courtney Marsh",coverURL:"https://cdn.intechopen.com/books/images_new/9785.jpg",editors:[{id:"255491",title:"Dr.",name:"Courtney",middleName:null,surname:"Marsh",slug:"courtney-marsh",fullName:"Courtney Marsh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7831",title:"Sustainability in Urban Planning and Design",subtitle:null,isOpenForSubmission:!1,hash:"c924420492c8c2c9751e178d025f4066",slug:"sustainability-in-urban-planning-and-design",bookSignature:"Amjad Almusaed, Asaad Almssad and Linh Truong - Hong",coverURL:"https://cdn.intechopen.com/books/images_new/7831.jpg",editors:[{id:"110471",title:"Dr.",name:"Amjad",middleName:"Zaki",surname:"Almusaed",slug:"amjad-almusaed",fullName:"Amjad Almusaed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9376",title:"Contemporary Developments and Perspectives in International Health Security",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"b9a00b84cd04aae458fb1d6c65795601",slug:"contemporary-developments-and-perspectives-in-international-health-security-volume-1",bookSignature:"Stanislaw P. Stawicki, Michael S. Firstenberg, Sagar C. Galwankar, Ricardo Izurieta and Thomas Papadimos",coverURL:"https://cdn.intechopen.com/books/images_new/9376.jpg",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7769",title:"Medical Isotopes",subtitle:null,isOpenForSubmission:!1,hash:"f8d3c5a6c9a42398e56b4e82264753f7",slug:"medical-isotopes",bookSignature:"Syed Ali Raza Naqvi and Muhammad Babar Imrani",coverURL:"https://cdn.intechopen.com/books/images_new/7769.jpg",editors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9279",title:"Concepts, Applications and Emerging Opportunities in Industrial Engineering",subtitle:null,isOpenForSubmission:!1,hash:"9bfa87f9b627a5468b7c1e30b0eea07a",slug:"concepts-applications-and-emerging-opportunities-in-industrial-engineering",bookSignature:"Gary Moynihan",coverURL:"https://cdn.intechopen.com/books/images_new/9279.jpg",editors:[{id:"16974",title:"Dr.",name:"Gary",middleName:null,surname:"Moynihan",slug:"gary-moynihan",fullName:"Gary Moynihan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7807",title:"A Closer Look at Organizational Culture in Action",subtitle:null,isOpenForSubmission:!1,hash:"05c608b9271cc2bc711f4b28748b247b",slug:"a-closer-look-at-organizational-culture-in-action",bookSignature:"Süleyman Davut Göker",coverURL:"https://cdn.intechopen.com/books/images_new/7807.jpg",editors:[{id:"190035",title:"Associate Prof.",name:"Süleyman Davut",middleName:null,surname:"Göker",slug:"suleyman-davut-goker",fullName:"Süleyman Davut Göker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"7434",title:"Molecular Biotechnology",subtitle:null,isOpenForSubmission:!1,hash:"eceede809920e1ec7ecadd4691ede2ec",slug:"molecular-biotechnology",bookSignature:"Sergey Sedykh",coverURL:"https://cdn.intechopen.com/books/images_new/7434.jpg",editedByType:"Edited by",editors:[{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",slug:"sergey-sedykh",fullName:"Sergey Sedykh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,isOpenForSubmission:!1,hash:"13aaddf5fdbbc78387e77a7da2388bf6",slug:"animal-reproduction-in-veterinary-medicine",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9569",title:"Methods in Molecular Medicine",subtitle:null,isOpenForSubmission:!1,hash:"691d3f3c4ac25a8093414e9b270d2843",slug:"methods-in-molecular-medicine",bookSignature:"Yusuf Tutar",coverURL:"https://cdn.intechopen.com/books/images_new/9569.jpg",editedByType:"Edited by",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9839",title:"Outdoor Recreation",subtitle:"Physiological and Psychological Effects on Health",isOpenForSubmission:!1,hash:"5f5a0d64267e32567daffa5b0c6a6972",slug:"outdoor-recreation-physiological-and-psychological-effects-on-health",bookSignature:"Hilde G. Nielsen",coverURL:"https://cdn.intechopen.com/books/images_new/9839.jpg",editedByType:"Edited by",editors:[{id:"158692",title:"Ph.D.",name:"Hilde G.",middleName:null,surname:"Nielsen",slug:"hilde-g.-nielsen",fullName:"Hilde G. Nielsen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7802",title:"Modern Slavery and Human Trafficking",subtitle:null,isOpenForSubmission:!1,hash:"587a0b7fb765f31cc98de33c6c07c2e0",slug:"modern-slavery-and-human-trafficking",bookSignature:"Jane Reeves",coverURL:"https://cdn.intechopen.com/books/images_new/7802.jpg",editedByType:"Edited by",editors:[{id:"211328",title:"Prof.",name:"Jane",middleName:null,surname:"Reeves",slug:"jane-reeves",fullName:"Jane Reeves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8063",title:"Food Security in Africa",subtitle:null,isOpenForSubmission:!1,hash:"8cbf3d662b104d19db2efc9d59249efc",slug:"food-security-in-africa",bookSignature:"Barakat Mahmoud",coverURL:"https://cdn.intechopen.com/books/images_new/8063.jpg",editedByType:"Edited by",editors:[{id:"92016",title:"Dr.",name:"Barakat",middleName:null,surname:"Mahmoud",slug:"barakat-mahmoud",fullName:"Barakat Mahmoud"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10118",title:"Plant Stress Physiology",subtitle:null,isOpenForSubmission:!1,hash:"c68b09d2d2634fc719ae3b9a64a27839",slug:"plant-stress-physiology",bookSignature:"Akbar Hossain",coverURL:"https://cdn.intechopen.com/books/images_new/10118.jpg",editedByType:"Edited by",editors:[{id:"280755",title:"Dr.",name:"Akbar",middleName:null,surname:"Hossain",slug:"akbar-hossain",fullName:"Akbar Hossain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9157",title:"Neurodegenerative Diseases",subtitle:"Molecular Mechanisms and Current Therapeutic Approaches",isOpenForSubmission:!1,hash:"bc8be577966ef88735677d7e1e92ed28",slug:"neurodegenerative-diseases-molecular-mechanisms-and-current-therapeutic-approaches",bookSignature:"Nagehan Ersoy Tunalı",coverURL:"https://cdn.intechopen.com/books/images_new/9157.jpg",editedByType:"Edited by",editors:[{id:"82778",title:"Ph.D.",name:"Nagehan",middleName:null,surname:"Ersoy Tunalı",slug:"nagehan-ersoy-tunali",fullName:"Nagehan Ersoy Tunalı"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9961",title:"Data Mining",subtitle:"Methods, Applications and Systems",isOpenForSubmission:!1,hash:"ed79fb6364f2caf464079f94a0387146",slug:"data-mining-methods-applications-and-systems",bookSignature:"Derya Birant",coverURL:"https://cdn.intechopen.com/books/images_new/9961.jpg",editedByType:"Edited by",editors:[{id:"15609",title:"Dr.",name:"Derya",middleName:null,surname:"Birant",slug:"derya-birant",fullName:"Derya Birant"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8686",title:"Direct Torque Control Strategies of Electrical Machines",subtitle:null,isOpenForSubmission:!1,hash:"b6ad22b14db2b8450228545d3d4f6b1a",slug:"direct-torque-control-strategies-of-electrical-machines",bookSignature:"Fatma Ben Salem",coverURL:"https://cdn.intechopen.com/books/images_new/8686.jpg",editedByType:"Edited by",editors:[{id:"295623",title:"Associate Prof.",name:"Fatma",middleName:null,surname:"Ben Salem",slug:"fatma-ben-salem",fullName:"Fatma Ben Salem"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"203",title:"Telemedicine",slug:"telemedicine",parent:{title:"Medicine",slug:"medicine"},numberOfBooks:6,numberOfAuthorsAndEditors:197,numberOfWosCitations:99,numberOfCrossrefCitations:87,numberOfDimensionsCitations:180,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"telemedicine",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8332",title:"Telehealth",subtitle:null,isOpenForSubmission:!1,hash:"dd9601c901f7fe3803ae69dbd571feba",slug:"telehealth",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/8332.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3269",title:"Telemedicine",subtitle:null,isOpenForSubmission:!1,hash:"16571516432b37129c1a7ef56c4cf3aa",slug:"telemedicine",bookSignature:"Ramesh Madhavan and Shahram Khalid",coverURL:"https://cdn.intechopen.com/books/images_new/3269.jpg",editedByType:"Edited by",editors:[{id:"158803",title:"Dr.",name:"Ramesh",middleName:null,surname:"Madhavan",slug:"ramesh-madhavan",fullName:"Ramesh Madhavan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2824",title:"eHealth and Remote Monitoring",subtitle:null,isOpenForSubmission:!1,hash:"fee1441d7fee8b6585fb3b4e43452da0",slug:"ehealth-and-remote-monitoring",bookSignature:"Amir Hajjam El Hassani",coverURL:"https://cdn.intechopen.com/books/images_new/2824.jpg",editedByType:"Edited by",editors:[{id:"17524",title:"Dr.",name:"Amir",middleName:null,surname:"Hajjam El Hassani",slug:"amir-hajjam-el-hassani",fullName:"Amir Hajjam El Hassani"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"199",title:"Telemedicine",subtitle:"Techniques and Applications",isOpenForSubmission:!1,hash:"0f4c17e1a24003fb78612525315af711",slug:"telemedicine-techniques-and-applications",bookSignature:"Georgi Graschew and Stefan Rakowsky",coverURL:"https://cdn.intechopen.com/books/images_new/199.jpg",editedByType:"Edited by",editors:[{id:"11262",title:"Dr.",name:"Georgi",middleName:null,surname:"Graschew",slug:"georgi-graschew",fullName:"Georgi Graschew"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1403",title:"Advances in Telemedicine",subtitle:"Applications in Various Medical Disciplines and Geographical Regions",isOpenForSubmission:!1,hash:"a8e4b1e59964db023e14fe11b26a232d",slug:"advances-in-telemedicine-applications-in-various-medical-disciplines-and-geographical-regions",bookSignature:"Georgi Graschew and Theo A. Roelofs",coverURL:"https://cdn.intechopen.com/books/images_new/1403.jpg",editedByType:"Edited by",editors:[{id:"11262",title:"Dr.",name:"Georgi",middleName:null,surname:"Graschew",slug:"georgi-graschew",fullName:"Georgi Graschew"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"43",title:"Advances in Telemedicine",subtitle:"Technologies, Enabling Factors and Scenarios",isOpenForSubmission:!1,hash:"45f56e0955035bdce490c5383a06792f",slug:"advances-in-telemedicine-technologies-enabling-factors-and-scenarios",bookSignature:"Georgi Graschew and Theo A. Roelofs",coverURL:"https://cdn.intechopen.com/books/images_new/43.jpg",editedByType:"Edited by",editors:[{id:"11262",title:"Dr.",name:"Georgi",middleName:null,surname:"Graschew",slug:"georgi-graschew",fullName:"Georgi Graschew"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:6,mostCitedChapters:[{id:"14328",doi:"10.5772/14352",title:"Telemedicine in Dentistry (Teledentistry)",slug:"telemedicine-in-dentistry-teledentistry-",totalDownloads:5220,totalCrossrefCites:7,totalDimensionsCites:14,book:{slug:"advances-in-telemedicine-applications-in-various-medical-disciplines-and-geographical-regions",title:"Advances in Telemedicine",fullTitle:"Advances in Telemedicine: Applications in Various Medical Disciplines and Geographical Regions"},signatures:"Branko Mihailovic, Milan Miladinovic and Biljana Vujicic",authors:[{id:"17551",title:"Dr.",name:"Milan",middleName:null,surname:"Miladinovic",slug:"milan-miladinovic",fullName:"Milan Miladinovic"},{id:"17555",title:"Dr.",name:"Branko",middleName:null,surname:"Mihailovic",slug:"branko-mihailovic",fullName:"Branko Mihailovic"},{id:"17556",title:"Dr.",name:"Biljana",middleName:null,surname:"Vujicic",slug:"biljana-vujicic",fullName:"Biljana Vujicic"}]},{id:"16882",doi:"10.5772/16362",title:"A 2.4GHz Non-Contact Biosensor System for Continuous Monitoring of Vital-Signs",slug:"a-2-4ghz-non-contact-biosensor-system-for-continuous-monitoring-of-vital-signs",totalDownloads:3812,totalCrossrefCites:8,totalDimensionsCites:13,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Donald Lie, Ravi Ichapurapu, Suyash Jain, Jerry Lopez, Ronald Banister, Tam Nguyen and John Griswold",authors:[{id:"24852",title:"Prof.",name:"Donald",middleName:null,surname:"Lie",slug:"donald-lie",fullName:"Donald Lie"},{id:"119104",title:"Dr.",name:"Ravi",middleName:null,surname:"Ichapurapu",slug:"ravi-ichapurapu",fullName:"Ravi Ichapurapu"},{id:"119105",title:"Dr.",name:"Suyash",middleName:null,surname:"Jain",slug:"suyash-jain",fullName:"Suyash Jain"},{id:"119106",title:"Dr.",name:"Jerry",middleName:null,surname:"Lopez",slug:"jerry-lopez",fullName:"Jerry Lopez"},{id:"119107",title:"Dr.",name:"Ronald",middleName:null,surname:"Banister",slug:"ronald-banister",fullName:"Ronald Banister"},{id:"119108",title:"Dr.",name:"Tam",middleName:null,surname:"Nguyen",slug:"tam-nguyen",fullName:"Tam Nguyen"},{id:"119109",title:"Dr.",name:"John",middleName:null,surname:"Griswold",slug:"john-griswold",fullName:"John Griswold"}]},{id:"45211",doi:"10.5772/56116",title:"The Telemedicine Service Maturity Model: A Framework for the Measurement and Improvement of Telemedicine Services",slug:"the-telemedicine-service-maturity-model-a-framework-for-the-measurement-and-improvement-of-telemedic",totalDownloads:2248,totalCrossrefCites:3,totalDimensionsCites:10,book:{slug:"telemedicine",title:"Telemedicine",fullTitle:"Telemedicine"},signatures:"Liezl van Dyk and Cornelius S.L. Schutte",authors:[{id:"27481",title:"Ms",name:"Liezl",middleName:null,surname:"Van Dyk",slug:"liezl-van-dyk",fullName:"Liezl Van Dyk"},{id:"166270",title:"Prof.",name:"Corne",middleName:null,surname:"Schutte",slug:"corne-schutte",fullName:"Corne Schutte"}]}],mostDownloadedChaptersLast30Days:[{id:"64650",title:"Barriers to Development of Telemedicine in Developing Countries",slug:"barriers-to-development-of-telemedicine-in-developing-countries",totalDownloads:1302,totalCrossrefCites:6,totalDimensionsCites:10,book:{slug:"telehealth",title:"Telehealth",fullTitle:"Telehealth"},signatures:"Surya Bali",authors:null},{id:"16881",title:"Clinical Decision Support Systems",slug:"clinical-decision-support-systems",totalDownloads:9157,totalCrossrefCites:4,totalDimensionsCites:9,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Dejan Dinevski, Uroš Bele, Tomislav Šarenac, Uroš Rajkovič and Olga Šušteršic",authors:[{id:"15129",title:"Prof.",name:"Dejan",middleName:null,surname:"Dinevski",slug:"dejan-dinevski",fullName:"Dejan Dinevski"},{id:"63337",title:"Dr.",name:"Uroš",middleName:null,surname:"Bele",slug:"uros-bele",fullName:"Uroš Bele"},{id:"63338",title:"MSc",name:"Tomislav",middleName:null,surname:"Sarenac",slug:"tomislav-sarenac",fullName:"Tomislav Sarenac"},{id:"63339",title:"Dr.",name:"Uroš",middleName:null,surname:"Rajkovi?",slug:"uros-rajkovi",fullName:"Uroš Rajkovi?"},{id:"63340",title:"Dr.",name:"Olga",middleName:null,surname:"Šušterši?",slug:"olga-sustersi",fullName:"Olga Šušterši?"}]},{id:"16889",title:"Telemedicine for Chronic Digestive Diseases: A Systematic Qualitative Review",slug:"telemedicine-for-chronic-digestive-diseases-a-systematic-qualitative-review",totalDownloads:2827,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Raymond Cross and Sandra Quezada",authors:[{id:"32822",title:"Dr.",name:"Raymond",middleName:null,surname:"Cross",slug:"raymond-cross",fullName:"Raymond Cross"},{id:"44475",title:"Dr.",name:"Sandra",middleName:null,surname:"Quezada",slug:"sandra-quezada",fullName:"Sandra Quezada"}]},{id:"38847",title:"Phonocardiogram Signal Processing Module for Auto-Diagnosis and Telemedicine Applications",slug:"phonocardiogram-signal-processing-module-for-auto-diagnosis-and-telemedicine-applications",totalDownloads:2396,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"ehealth-and-remote-monitoring",title:"eHealth and Remote Monitoring",fullTitle:"eHealth and Remote Monitoring"},signatures:"Ali Moukadem, Alain Dieterlen and Christian Brandt",authors:[{id:"144059",title:"Dr.",name:"Ali",middleName:null,surname:"Moukadem",slug:"ali-moukadem",fullName:"Ali Moukadem"},{id:"144067",title:"Prof.",name:"Alain",middleName:null,surname:"Dieterlen",slug:"alain-dieterlen",fullName:"Alain Dieterlen"},{id:"144068",title:"Dr.",name:"Christian",middleName:null,surname:"Brandt",slug:"christian-brandt",fullName:"Christian Brandt"}]},{id:"16875",title:"Pervasive Homecare Monitoring Technologies and Applications",slug:"pervasive-homecare-monitoring-technologies-and-applications",totalDownloads:3254,totalCrossrefCites:1,totalDimensionsCites:2,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Demosthenes Vouyioukas and Alexandros Karagiannis",authors:[{id:"40966",title:"MSc",name:"Alexandros",middleName:null,surname:"Karagiannis",slug:"alexandros-karagiannis",fullName:"Alexandros Karagiannis"},{id:"43110",title:"Prof.",name:"Demosthenes",middleName:null,surname:"Vouyioukas",slug:"demosthenes-vouyioukas",fullName:"Demosthenes Vouyioukas"}]},{id:"16878",title:"QoS in Telemedicine",slug:"qos-in-telemedicine",totalDownloads:3103,totalCrossrefCites:4,totalDimensionsCites:7,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Phumzile Malindi",authors:[{id:"38001",title:"Dr.",name:"Phumzile",middleName:null,surname:"Malindi",slug:"phumzile-malindi",fullName:"Phumzile Malindi"}]},{id:"16882",title:"A 2.4GHz Non-Contact Biosensor System for Continuous Monitoring of Vital-Signs",slug:"a-2-4ghz-non-contact-biosensor-system-for-continuous-monitoring-of-vital-signs",totalDownloads:3812,totalCrossrefCites:8,totalDimensionsCites:13,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Donald Lie, Ravi Ichapurapu, Suyash Jain, Jerry Lopez, Ronald Banister, Tam Nguyen and John Griswold",authors:[{id:"24852",title:"Prof.",name:"Donald",middleName:null,surname:"Lie",slug:"donald-lie",fullName:"Donald Lie"},{id:"119104",title:"Dr.",name:"Ravi",middleName:null,surname:"Ichapurapu",slug:"ravi-ichapurapu",fullName:"Ravi Ichapurapu"},{id:"119105",title:"Dr.",name:"Suyash",middleName:null,surname:"Jain",slug:"suyash-jain",fullName:"Suyash Jain"},{id:"119106",title:"Dr.",name:"Jerry",middleName:null,surname:"Lopez",slug:"jerry-lopez",fullName:"Jerry Lopez"},{id:"119107",title:"Dr.",name:"Ronald",middleName:null,surname:"Banister",slug:"ronald-banister",fullName:"Ronald Banister"},{id:"119108",title:"Dr.",name:"Tam",middleName:null,surname:"Nguyen",slug:"tam-nguyen",fullName:"Tam Nguyen"},{id:"119109",title:"Dr.",name:"John",middleName:null,surname:"Griswold",slug:"john-griswold",fullName:"John Griswold"}]},{id:"16884",title:"Clinical Psychology and Medicine for the Treatment of Obesity in Out-patient Settings: The TECNOB Project",slug:"clinical-psychology-and-medicine-for-the-treatment-of-obesity-in-out-patient-settings-the-tecnob-pro",totalDownloads:1724,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Gianluca Castelnuovo, Gian Mauro Manzoni , Stefania Corti, Paola Cuzziol, Valentina Villa and Enrico Molinari",authors:[{id:"35298",title:"Prof.",name:"Gianluca",middleName:null,surname:"Castelnuovo",slug:"gianluca-castelnuovo",fullName:"Gianluca Castelnuovo"}]},{id:"16890",title:"Teledermatology: Outcomes and Economic Considerations",slug:"teledermatology-outcomes-and-economic-considerations",totalDownloads:2558,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Akhilesh Pathipati and April Armstrong",authors:[{id:"32510",title:"Dr.",name:"April",middleName:"Wang",surname:"Armstrong",slug:"april-armstrong",fullName:"April Armstrong"},{id:"37945",title:"Mr",name:"Akhilesh",middleName:"Srinivas",surname:"Pathipati",slug:"akhilesh-pathipati",fullName:"Akhilesh Pathipati"}]},{id:"16893",title:"Telemedical Solutions - Practical Approach in Bulgaria",slug:"telemedical-solutions-practical-approach-in-bulgaria",totalDownloads:1934,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Polina Mihova",authors:[{id:"27174",title:"Dr.",name:"Polina",middleName:"Mihova",surname:"Mihova",slug:"polina-mihova",fullName:"Polina Mihova"}]}],onlineFirstChaptersFilter:{topicSlug:"telemedicine",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/22886/daniela-mueller",hash:"",query:{},params:{id:"22886",slug:"daniela-mueller"},fullPath:"/profiles/22886/daniela-mueller",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()